Anchor magazine

Information

  • Patent Grant
  • 10299793
  • Patent Number
    10,299,793
  • Date Filed
    Tuesday, October 21, 2014
    10 years ago
  • Date Issued
    Tuesday, May 28, 2019
    5 years ago
Abstract
Apparatus is provided, the apparatus comprising (i) a housing (22, 222), shaped to define a channel (24, 224) having an anchor-storage zone (26, 226) and an opening (28, 228) configured to provide access for an anchor driver (60) to the anchor-storage zone; (ii) a tissue anchor (40), stored in the anchor-storage zone and slidable through the channel; and (iii) a retaining member (30, 230). The retaining member (a) has a retaining state in which the retaining member is configured to retain the tissue anchor in the anchor-storage zone, and (b) is configured, by moving in response to a proximally-directed force applied to the tissue anchor, to allow the tissue anchor to leave the anchor-storage zone in response to the proximally-directed force. The proximally-directed force is greater than a pre-determined threshold force. Other embodiments are described.
Description
FIELD OF THE INVENTION

The present invention relates in general to handling of tissue anchors. More specifically, the present invention relates to devices and techniques for handling of a plurality of tissue anchors, and the use thereof at a heart valve of a patient.


BACKGROUND

Tissue anchors are placed intracorporeally so as to anchor implants to a tissue of a subject. Typically, this intracorporeal placement necessitates that the tissue anchors are small, e.g., having a greatest dimension (e.g., a length) of less than 11 mm and/or a maximum width of 3 mm. It is therefore typically advantageous to provide devices and techniques to facilitate handling of the tissue anchors.


SUMMARY OF THE INVENTION

An anchor-handling device is configured to facilitate handling of one or more tissue anchors. The anchor-handling device retains the anchors within an anchor-storage zone of a channel defined by a housing until a tool such as an anchor driver is used to retrieve the anchor. The tool is advanced through the channel, coupled to the anchor, and removed proximally out of the channel with the anchor. The anchor-handling device is configured to release (e.g., dispense) the anchor only when a proximally-directed force applied by the tool to the anchor is greater than a pre-defined threshold force (i.e., is sufficient), so as to prevent inadvertent exit of the anchor.


A retaining member is configured to retain the tissue anchor in the anchor-storage zone, typically by obstructing exit of the tissue anchor. The sufficient proximally-directed force moves the retaining member out of the way of the anchor, e.g., by moving the anchor to push the retaining member out of the way. Typically, an inhibitor inhibits movement of the retaining member, thereby configuring the retaining member to move out of the way of the anchor only in response to the sufficient proximally-directed force.


For some applications, the anchor-handling device is used in combination with a multi-component tubular system for transcatheter delivery of an implant, e.g., to facilitate sequential delivery of a plurality of anchors to the implant via the system.


There is therefore provided, in accordance with an application of the present invention, apparatus for use with an anchor driver, the apparatus including:


a housing, shaped to define a channel having an anchor-storage zone and a proximal opening configured to provide access for the anchor driver to the anchor-storage zone;


a tissue anchor, stored in the anchor-storage zone and slidable through the channel; and


a retaining member:

    • having a retaining state in which the retaining member is configured to retain the tissue anchor in the anchor-storage zone, and
    • being configured, by moving in response to a proximally-directed force applied to the tissue anchor, to allow the tissue anchor to leave the anchor-storage zone in response to the proximally-directed force, the proximally-directed force being greater than a pre-determined threshold force.


In an application, the apparatus is configured such that after removal of the tissue anchor from the housing, a distally-directed force required to return the apparatus to the retaining state is more than twice as great as the threshold force.


In an application, the retaining member is configured such that the threshold force is 300-1500 grams force.


In an application, the tissue anchor has a mass, and the retaining member is configured such that the threshold force, measured in grams force, is 1000-150,000 times greater than the mass of the tissue anchor, measured in grams.


In an application, the apparatus further includes an inhibitor, configured to configure the retaining member to (i) retain the tissue anchor in the anchor-storage zone, and (ii) to allow the tissue anchor to leave the anchor-storage zone in response to the proximally-directed force.


In an application, the tissue anchor is dimensioned to fit snugly in the anchor-storage zone.


In an application, the apparatus further includes a multi-component tubular system for transcatheter implantation of an implant into a subject, the implant configured to be anchored to tissue of the subject using the tissue anchor, and the housing being coupled to a component of the multi-component tubular system.


In an application, the component of the multi-component tubular system includes a stand, and the housing is coupled to the stand.


In an application, the multi-component tubular system defines a proximal port through which the anchor is introducible, and the housing is coupled to the component of the multi-component tubular system such that the proximal opening of the housing is disposed between 1 and 40 cm from the port of the multi-component tubular system.


In an application, the multi-component tubular system defines a proximal port through which the anchor is introducible, and the housing is coupled to the component of the multi-component tubular system such that the proximal opening of the housing faces generally the same direction as the port of the multi-component tubular system.


In an application:


the housing is configured to define a plurality of channels, each of the plurality of channels having a respective anchor-storage zone and a respective proximal opening, and


the apparatus includes a plurality of tissue anchors, slidable through a respective channel and configured to be stored in a respective anchor-storage zone.


In an application, the apparatus includes a plurality of retaining members, each retaining member configured to retain a respective tissue anchor in the respective anchor-storage zone, and to allow the respective tissue anchor to leave the respective anchor-storage zone in response to a proximally-directed force applied to the respective tissue anchor.


In an application, in the retaining state, at least a portion of the retaining member obstructs proximal movement of the tissue anchor by being disposed within the channel.


In an application, the apparatus further includes the anchor driver, and in the retaining state, the anchor driver is slidable through the channel and lockable to the tissue anchor while at least the portion of the retaining member obstructs proximal movement of the tissue anchor by being disposed within the channel.


In an application, in the retaining state, the anchor driver is slidable through the channel such that a part of the anchor driver becomes positioned between a part of the tissue anchor and a part of the retaining member, and the anchor driver is lockable to the tissue anchor only while the part of the anchor driver is positioned between the part of the tissue anchor and the part of the retaining member.


In an application:


the tissue anchor includes a core, a tissue-engaging member coupled to a distal side of the core, and a coupling head coupled to a proximal side of the core, and


in the retaining state, at least the portion of the retaining member that obstructs the proximal movement of the tissue anchor obstructs the proximal movement of the tissue anchor by engaging the core.


In an application:


the housing is shaped to define a chamber that is in fluid communication with the channel,


at least part of the retaining member is configured to slide within the chamber in response to the proximally-directed force applied to the tissue anchor.


In an application, a first end of the chamber is in fluid communication with the channel, the housing defines a chamber opening of the chamber at a second end of the chamber, the portion of the retaining member includes a first portion of the retaining member, and the retaining member is configured such that, in response to the proximally-directed force applied to the tissue anchor, a second portion of the retaining member moves out of the chamber opening.


In an application, the retaining member is configured such that, in response to the proximally-directed force applied to the tissue anchor, a second portion of the retaining member moves out of the housing.


In an application, the apparatus is configured such that after removal of the tissue anchor from the housing, a distally-directed force required to return the apparatus to the retaining state is more than twice as great as the threshold force.


In an application, the retaining member includes a pin, configured to slide through the chamber.


In an application:


the housing is shaped to define a cavity that is in fluid communication with the chamber,


at least a portion of the retaining member is resilient,


the retaining member is shaped to define a detent,


in the retaining state, the resilience of at least the portion of the retaining member holds the detent within the cavity, and


the retaining member is configured to deform in response to the proximally-directed force applied to the tissue anchor, such that the detent exits the cavity.


In an application:


the cavity includes a first cavity,


the housing is shaped to define a second cavity that is in fluid communication with the chamber, and


the apparatus is dimensioned such that when the retaining member allows the tissue anchor to leave the anchor-storage zone, further proximal movement of the retaining member causes the detent to move into the second cavity.


In an application, the second cavity is larger in at least one dimension than the first cavity.


In an application, the second cavity is differently shaped to the first cavity.


In an application, the second cavity and the detent are dimensioned such that when the detent is disposed within the second cavity, a distally-directed force required to return the apparatus to the retaining state is more than twice as great as the threshold force.


In an application, at least a portion of the pin is dimensioned to slide snugly through the chamber.


In an application, the apparatus further includes an inhibitor tongue having a pin-contacting portion that is in contact with the pin, and configured to (i) inhibit the pin from sliding through the chamber in response to a sub-threshold force, and (ii) to allow the pin to slide through the chamber in response to the proximally-directed force applied to the tissue anchor.


In an application:


the pin is shaped to define a cavity,


at least a portion of the inhibitor tongue is resilient,


in the retaining state, the resilience of at least the portion of the inhibitor tongue holds the pin-contacting portion within the cavity, and


the inhibitor tongue is configured to deform in response to the proximally-directed force applied to the tissue anchor, such that the pin-contacting portion exits the cavity.


In an application:


the cavity includes a first cavity.


the pin is shaped to define a second cavity,


the apparatus is dimensioned such that when the retaining member allows the tissue anchor to leave the anchor-storage zone, further proximal movement of the retaining member causes the pin-contacting portion to move into the second cavity.


In an application, the second cavity is larger in at least one dimension than the first cavity.


In an application, the second cavity is differently shaped to the first cavity.


In an application, the second cavity and the pin-contacting portion are dimensioned such that when the pin-contacting portion is disposed within the second cavity, a distally-directed force required to return the apparatus to the retaining state is more than twice as great as the threshold force.


In an application, the chamber is in fluid communication with the channel at a distal end of the chamber, and has a proximal-distal longitudinal axis that is disposed at between 5 and 30 degrees from a proximal-distal longitudinal axis of the channel.


In an application, the proximal-distal longitudinal axis of the chamber is disposed at between 5 and 20 degrees from the proximal-distal longitudinal axis of the channel


In an application, the proximal-distal longitudinal axis of the chamber is disposed at between 11 and 14 degrees from the proximal-distal longitudinal axis of the channel.


In an application, a central longitudinal axis of the chamber is parallel with a central longitudinal axis of the channel.


In an application, the tissue anchor is dimensioned to fit snugly through the channel.


In an application, the tissue anchor includes a core, a tissue-engaging member coupled to a distal side of the core, and a coupling head, the core is dimensioned to fit snugly through the channel, and the tissue-engaging member is dimensioned so as to not touch the housing when the tissue anchor moves through the channel.


In an application, the apparatus further includes the anchor driver.


In an application, the anchor driver includes:


at a distal end thereof, an anchor-engaging head introducible through the opening of the housing and actuatable to be reversibly coupled to the tissue anchor;


at a proximal end thereof, a handle including an adjuster configured to actuate the anchor-engaging head; and


a flexible shaft:

    • disposed between the distal end of the anchor driver and the proximal end of the anchor driver,
    • having a length of 50-250 cm, and
    • configured to be transcatheterally advanced through vasculature of a subject.


In an application, the opening of the housing is rotationally asymmetrical, a transverse cross-section of the anchor-engaging head is rotationally asymmetrical, and the opening limits a range of rotational orientations of the anchor-engaging head with respect to the opening in which the anchor-engaging head is introducible through the opening.


In an application, the opening of the housing and the transverse cross-section of the anchor-engaging head each have the shape of an ellipse that has had a segment removed.


In an application, the tissue anchor is stored in the anchor-storage zone in a given rotational orientation of the tissue anchor with respect to the opening, the anchor-engaging head is couplable to the tissue anchor in not all rotational orientations of the head with respect to the tissue anchor, and the anchor-engaging head is couplable to the tissue anchor without rotating the anchor-engaging head subsequently to introducing the anchor-engaging head through the opening.


In an application, the opening limits the range of rotational orientations such that the anchor-engaging head is introducible through the opening in only a given rotational orientation of the head with respect to the opening.


In an application, the apparatus further includes a base, and:


the housing is couplable to the base,


the base is configured to at least partly immobilize the housing, and


the base is shaped to define a receptacle for housing and at least partly immobilizing the handle.


In an application, when the housing is coupled to the base, the housing is disposed less than 30 cm from the receptacle.


In an application:


the receptacle is a handle receptacle,


the housing is reversibly couplable to the base,


the base is shaped to further define a housing receptacle, configured to house the housing,


the base further includes a locking element, movable between a locked state that locks the housing within the receptacle, and an unlocked state that facilitates release of the housing from the receptacle.


In an application, the adjuster is operable while the receptacle houses the handle.


In an application, the apparatus is configured such that while the receptacle houses the handle, a human operator may:


with a first hand of the operator, grasp a distal portion of the driver and introduce the head into the opening, and


with a second hand of the operator, reversibly actuate the head by operating the adjuster while grasping the distal portion of the driver with the first hand.


There is further provided, in accordance with an application of the present invention, apparatus for use with an anchor driver, the apparatus including:


a housing, shaped to define a channel having (a) an anchor-storage zone and (b) a proximal opening configured to provide access for the anchor driver to the anchor-storage zone;


a tissue anchor, slidable through the channel and configured to be stored in the anchor-storage zone; and


a retaining member:

    • having a retaining state in which the retaining member is configured to retain the tissue anchor in the anchor-storage zone, and
    • being disposed within the housing such that sliding of the tissue anchor proximally out of the anchor-storage zone and through the channel causes the retaining member to slide in an at least partly proximal direction.


In an application, the retaining member is disposed within the housing such that sliding of the tissue anchor proximally out of the anchor-storage zone and through the channel causes the retaining member to slide along an axis that is disposed at an angle of less than 30 degrees with respect to a central longitudinal axis of the channel.


There is further provided, in accordance with an application of the present invention, apparatus, including:


a housing, shaped to define a channel having an anchor-storage zone and a proximal opening;


an anchor driver including an anchor-engaging head, a handle, and a shaft therebetween, and:

    • the shaft is flexible and is configured to be transluminally advanced into a subject, and
    • the anchor-engaging head is dimensioned to be advanceable through the proximal opening toward the anchor-storage zone; and


      a tissue anchor:
    • stored in the anchor-storage zone,
    • including (i) a coupling head configured to be locked to the anchor-engaging head while the tissue anchor is in the anchor-storage zone, and (ii) a tissue-engaging member configured to be driven into tissue of the subject using the anchor driver, and
    • configured such that, while stored in the anchor-storage zone, the tissue anchor is movable out of the anchor-storage zone toward the proximal opening only in response to a proximally-directed force being applied to the tissue anchor, the proximally-directed force being greater than a pre-determined threshold force.


In an application, the tissue anchor is configured to be movable out of the anchor-storage zone only in response to the proximally-directed force, by being dimensioned with respect to at least one dimension of the housing such that the tissue anchor is movable out of the anchor-storage zone only in response to the proximally-directed force.


There is further provided, in accordance with an application of the present invention, apparatus, including:


an anchor-handling device including a housing, shaped to define a channel having an anchor-storage zone and a proximal opening;


an anchor driver including an anchor-engaging head, a handle, and a shaft therebetween, and:

    • the shaft is flexible and is configured to be transluminally advanced into a subject, and
    • the anchor-engaging head is dimensioned to be advanceable through the proximal opening toward the anchor-storage zone; and


      a tissue anchor:
    • stored in the anchor-storage zone,
    • including (i) a coupling head configured to be locked to the anchor-engaging head while the tissue anchor is in the anchor-storage zone, and (ii) a tissue-engaging member configured to be driven into tissue of the subject using the anchor driver, and
    • configured such that, while stored in the anchor-storage zone, the tissue anchor is movable out of the anchor-storage zone toward the proximal opening in response to a proximally-directed force being applied to the tissue anchor by the anchor driver,


and the anchor-handling device is configured to provide an indication of the movement of the tissue anchor out of the anchor-storage zone toward the proximal opening in response to the proximally-directed force.


In an application, the anchor-handling device is configured to provide the indication by the housing being at least in part transparent, such that the movement of the tissue anchor is viewable from outside the housing.


In an application, the anchor-handling device is configured to provide the indication by including an element that moves with respect to the housing in response to the movement of the tissue anchor.


In an application, the element that moves with respect to the housing moves out of the housing in response to the movement of the tissue anchor.


In an application, the element that moves with respect to the housing moves with respect to the housing at a rate that is relative to a rate at which the anchor moves with respect to the housing.


The present invention will be more fully understood from the following detailed description of applications thereof, taken together with the drawings, in which:





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1A-F are schematic illustrations of an anchor-handling device, configured to facilitate handling of at least one tissue anchor, in accordance with some applications of the invention;



FIG. 2 is a schematic illustration of a multiple-anchor-handling device, in accordance with some applications of the invention;



FIGS. 3A-C are schematic illustrations of a system for transcatheter delivery of an implant, and anchoring of the implant using an anchor driver and a plurality of anchors provided in the multiple-anchor-handling device of FIG. 2, in accordance with some applications of the invention;



FIGS. 4A-F are schematic illustrations of an anchor-handling device, configured to facilitate handling of at least one tissue anchor, in accordance with some applications of the invention; and



FIGS. 5A-C are schematic illustrations of a base to which an anchor-handling device is couplable, and which is configured to at least partly immobilize the anchor-handling device, in accordance with some applications of the invention.





DETAILED DESCRIPTION OF EMBODIMENTS

Reference is made to FIGS. 1A-F, which are schematic illustrations of an anchor-handling device 20, configured to facilitate handling of at least one tissue anchor 40, in accordance with some applications of the invention. Device 20 comprises a housing 22 that defines a channel 24, an anchor-storage zone 26 (e.g., at a distal end of the channel) and an opening 28 (e.g., at a proximal end of the channel) that provides access to the channel and the anchor-storage zone. Typically, there is a smooth transition between anchor-storage zone 26 and channel 24. Device 20 further comprises a retaining member, such as a pin 30, which is configured to retain tissue anchor 40 in zone 26, and to stop retaining the tissue anchor in response to a sufficient proximally-directed force applied to the tissue anchor. That is, when a proximally-directed force that is greater than a predetermined threshold force is applied to tissue anchor 40, the retaining member stops retaining (e.g., releases) the tissue anchor.


Typically, the retaining member (e.g., pin 30) has a retaining state in which it retains tissue anchor 40 within zone 26, and is moved out the retaining state when the sufficient proximally-directed force is applied to the tissue anchor. FIG. 1A shows, in accordance with some applications of the invention, pin 30 in a retaining state thereof, in which at least a portion 29 (e.g., an obstructing portion, and/or a distal portion) of the pin is disposed within channel 24 (e.g., proximal to anchor 40), thereby retaining the anchor in zone 26 by obstructing proximal movement of the tissue anchor. Typically, portion 29 obstructs proximal movement of anchor 40 by engaging and/or obstructing core 41 of the anchor (described hereinbelow).


It is to be noted that although pin 30 is shown as being generally cylindrical (i.e., having a generally circular transverse cross-section), the term “pin”, as used throughout the present application, including the specification and the claims, may include a pin having a different shape (e.g., having a noncircular transverse cross-section). For example, pin 230 (described hereinbelow with reference to FIGS. 4A-5C) typically has a rectangular cross-section.



FIG. 1A shows an anchor driver 60 being advanced toward opening 28 of channel 24, and FIG. 1B shows the anchor driver having been further advanced into and through channel 24, to anchor 40. As more clearly shown in FIGS. 1A and 1F, opening 28 is typically beveled (i.e., disposed at an angle smaller than 90 degrees to a longitudinal axis of channel 24), such that the opening has a greater area than does a transverse cross section of the channel, thereby facilitating introduction of driver 60 into the channel. It is to be noted that the shape of opening 28 provides a proximal region 25 in which channel 24 is at least half open on a lateral side (i.e., at least half of the circumferential surface of the channel is missing). This shape thereby facilitates placement of a driver head 62 of driver 60 in proximal region 25 of channel 24, e.g., by reducing a requirement for the driver to be aligned with the channel before its introduction into the channel. Driver 60 (e.g., head 62 thereof) can subsequently be advanced further into channel 24, using region 25 as a guide track.


Driver 60 typically comprises an anchor-engaging head 62 at a distal end of the driver, and a shaft 64 proximal to the anchor-engaging head. Shaft 64 is flexible and advanceable (e.g., transcatheterally) through vasculature of a subject, and typically has a length greater than 20 cm, and/or less than 2.5 m, such as greater than 50 cm and/or less than 1.5 m, e.g., between 0.9 m and 1.2 m. For some applications, driver 60 comprises a handle 66 at a proximal end of shaft 64, the handle comprising an adjuster 68 (e.g., a switch or a lever) configured to actuate engaging head 62.


Tissue anchor 40 typically comprises a core 41, a tissue-engaging member 44 coupled to a distal side of the core, and a coupling head 42 coupled to a proximal side of the core. Engaging head 62 is configured to be reversibly couplable to tissue anchor 40 (e.g., to coupling head 42 thereof), so as to facilitate acquisition of the anchor from device 20, driving of the anchor into tissue of the subject, and subsequent release of the anchor and withdrawal of driver 60 from the subject. For example, actuation of engaging head 62 by adjuster 68 may comprise transitioning the engaging head between (i) an open state in which the engaging head is configured to receive and/or release anchor 40 (FIGS. 1A-B), and (ii) a closed state in which the engaging head, having received the anchor (FIG. 1C), is coupled (e.g., locked) to the anchor.



FIG. 1B shows engaging head 62 having received anchor 40, but not yet coupled (e.g., locked) to the anchor. It is to be noted that in this position part of driver 60 (e.g., head 62) is disposed (e.g., sandwiched) between part of the retaining member (e.g., portion 29) and part of the anchor (e.g., coupling head 42).



FIG. 1C shows engaging head 62 being coupled (e.g., locked) to anchor 40. For some applications of the invention, engaging head 62 comprises a detent 70 that is transitioned into the closed state when a controller, such as a rod or a wire 72, is moved distally by adjuster 68, and automatically transitions back into the open state when the wire is withdrawn. FIG. 1C shows wire 72 having been moved distally into engaging head 62, and detent 70 having been pushed into the closed state, thereby coupling the engaging head to anchor 40 (e.g., to coupling head 42 thereof).



FIGS. 1D-E show anchor 40 being withdrawn proximally from zone 26 of channel 24 by the sufficient proximally-directed force being applied to the anchor by driver 60. As described hereinabove, in response to the sufficient proximally-directed force applied to the tissue anchor (i.e., if the proximally-directed force is greater than the pre-determined threshold force), the retaining member (e.g., pin 30) stops retaining the tissue anchor in zone 26. For example, and as shown in FIGS. 1D-E, the sufficient proximally-directed force overcomes the retention provided by pin 30 and pushes portion 29 of pin 30 out of the channel and into a chamber 74 that is in fluid communication with the channel (at least part of pin 30 thereby sliding within the chamber).


It is hypothesized that this configuring of device 20 to require that the sufficient proximally-directed force be applied to tissue anchor 40 prevents inadvertent movement and/or exit of the tissue anchor (e.g., due to general transport or handling of the device), and/or withdrawal of the anchor by driver 60 when the driver is sub-optimally coupled to the anchor.


For some applications, a first end 76 of chamber 74 is in fluid communication with channel 24, housing 22 defines an opening 78 at a second end of the chamber, and the pushing of portion 29 of pin 30 by the sufficient proximally-directed force pushes a second (e.g., proximal) portion 31 of the pin out of opening 78. This feature and advantages thereof are described in more detail hereinbelow. Typically, chamber 74 has a proximal-distal longitudinal axis that is disposed at between 5 and 30 degrees, e.g., 5-20 degrees (e.g., 5-15 degrees or 10-20 degrees, such as between 11 and 14 degrees) with respect to the longitudinal axis of channel 24. It is hypothesized that, for some applications, this angular disposition of the channel and chamber facilitates the above described movement of pin 30 in response to the sufficient proximally-directed force applied to the tissue anchor.



FIG. 1F shows anchor 40 having been fully withdrawn out of channel 24 via opening 28. Once anchor 40 has been fully withdrawn, driver 60 may be used to anchor tissue anchor 40 to tissue of a subject, e.g., by driving tissue-engaging member 44 (FIG. 1A) of the anchor into the tissue. It may be used as a tissue anchor as is known in the art. For example, using driver 60, anchor 40 may be advanced through a transluminal implant-delivery system and used to couple an implant to tissue of a subject, e.g., as described hereinbelow with reference to FIGS. 3A-C.


For some applications, device 20 comprises an inhibitor, configured to configure the retaining member (e.g., pin 30) to (i) retain the tissue anchor in anchor-storage zone 26, and (ii) to stop retaining the tissue anchor in response to the sufficient proximally-directed force. For example, the inhibitor may comprise an inhibitor tongue 80, that has a pin-contacting portion 82 (e.g., a pin-contacting surface) that is in contact with pin 30, and that provides resistance that (i) inhibits sliding of the pin through chamber 74 (e.g., prevents sliding of the pin in response to an insufficient proximally-directed force, i.e., a proximally-directed force that is less than the pre-determined threshold force), and (ii) allows sliding of the pin through the chamber in response to the sufficient proximally-directed force that is greater than the pre-determined threshold force being applied to tissue anchor 40. Pin-contacting portion 82 is typically held in contact with pin 30 by a spring mechanism. For example, and as shown in FIGS. 1A-F, inhibitor tongue 80 may comprise an elastically-deformable (e.g., shape-memory) material, and may be coupled to housing 22 by in a manner in which the inhibitor tongue itself provides the spring mechanism.


For some applications, pin 30 defines a cavity 32 therein (e.g., a recess or a notch in a lateral side of the pin), in which pin-contacting portion 82 is typically disposed while anchor 40 is disposed within anchor-storage zone 26 (e.g., in a state in which the device is provided). For such applications, portion 82 serves as a detent. For such applications, cavity 32 and inhibitor tongue 80 are configured such that when a proximally-directed force equal to or greater than the threshold force is applied to anchor 40, pin 30 is pushed against pin-contacting portion 82, and inhibitor tongue 80 responsively deforms such that the pin-contacting portion moves out of cavity 32, allowing pin 30 to move further proximally (FIG. 1D). Typically, for such applications, once portion 82 has moved out of cavity 32, a proximally-directed force that is smaller than the threshold force is sufficient to move pin 30 further proximally. That is, once the initial resistance provided by the inhibitor is overcome, anchor 40 is further withdrawable using a smaller force than that required to overcome the initial resistance.


(It will be understood by those skilled in the art that it is possible to use other configurations to achieve a behavior similar to that described above. For example, housing 22 may define a cavity, and pin 30 may comprise a flexible protrusion that extends into the cavity of the housing.)


For some applications, the inhibitor (e.g., tongue 80) provides the resistance by applying friction against the retaining member (e.g., pin 30). For example, pin-contacting portion 82 may comprise a high-friction pin-contacting surface.


Reference is made to FIG. 2, which is a schematic illustration of a multiple-anchor-handling device 100, in accordance with some applications of the invention. Device 100 defines a plurality of channels 24, each channel having a respective proximal opening 28 and a respective anchor-storage zone 26 that is configured to store a respective tissue anchor 40 (zone 26 and anchor 40 not visible in FIG. 2). Typically, device 100 further comprises a plurality of retaining members (e.g., pins 30), each retaining member being configured to retain a respective tissue anchor in its respective anchor-storage zone 26, and to stop retaining the respective tissue anchor in response to the sufficient proximally-directed force being applied to its respective tissue anchor. For some applications, device 100 comprises a plurality of devices 20. For example, device 100 may comprise a plurality of housings 22, each housing defining exactly one channel 24 and exactly one retaining member (e.g., pin 30).


As described hereinabove, for some applications, the sufficient proximally-directed force pushes a second (e.g., proximal) portion 31 of pin 30 out of opening 78 of chamber 74. Therefore, when driver 60 is withdrawn proximally, movement of portion 31 toward and/or out of opening 78 indicates that anchor-engaging head 62 has been successfully coupled to tissue anchor 40, and that the tissue anchor is also being withdrawn proximally. Thus, during an initial partial withdrawal of driver 60, movement of portion 31 toward and/or out of opening 78 provides an indication to the operator (e.g., physician) to continue to withdraw driver 60, whereas absence of such movement of portion 31 provides an indication to the operator to reattempt coupling of the driver to tissue anchor 40.


Following removal of anchor 40 from channel 24, portion 31 remains exposed from opening 78. This may be particularly useful for a physician using a multiple-anchor-handling device, such as device 100, e.g., to prevent the physician inadvertently attempting to obtain an anchor from an empty zone 26. That is, portion 31 functions as an empty-housing indicator.


For some applications, pin 30 defines a second cavity 34 therein (e.g., a second notch in a lateral side of the pin), disposed closer to distal portion 29 than is cavity 32. Second cavity 34 is positioned such that when (1) distal portion 29 is no longer obstructing anchor 40, and (2) second portion 31 is exposed out of opening 78, pin-engaging portion 82 of inhibitor tongue 80 moves into the second cavity (e.g., as shown in FIG. 1E). In this state, tongue 80 inhibits pin 30 from moving distally back into housing 22, thereby increasing the reliability of portion 31 functioning as an empty-housing indicator. For some applications, and as shown in FIGS. 1A-F, second cavity 34 is shaped such that once portion 82 has moved into (e.g., engaged) second cavity 34, the moving of portion 31 back into housing 22 requires a distally-directed force that is more than twice as great (in the opposite direction) as the threshold force that was previously required to move portion 31 out of the housing. For example, the moving of portion 31 back into housing 22 may be in effect prevented.


Reference is made to FIGS. 3A-C, which are schematic illustrations of a multi-component tubular system 120 for transcatheter delivery of an implant 140, and anchoring of the implant using anchor driver 60 and a plurality of anchors 40 provided in multiple-anchor-handling device 100, in accordance with some applications of the invention. Implant 140 comprises an annuloplasty structure comprising a sleeve 142, a flexible elongated contracting member 144 that extends along the sleeve, and an adjustment mechanism 146 which facilitates contracting and expanding of the annuloplasty structure. Typically, adjustment mechanism 146 comprises a spool around which successive portions of member 144 are wound in order to contract the annuloplasty structure after implantation.


Implant 140 is configured to be anchored to an annulus 10 of a valve of the heart 12 of a subject, such as a mitral valve 14 of the subject, and to change a dimension of the annulus when contracted or expanded using adjustment mechanism 146.


System 120 comprises one or more steerable catheters, and typically comprises an outer catheter 122 and an inner catheter 124 that is advanceable through the outer catheter. Outer catheter 122 is advanceable and steerable using a first handle 126, and inner catheter 124 is advanceable and steerable using a second handle 128. Typically, second handle 128 is couplable (e.g., lockable) to first handle 126, e.g., after advancement of catheter 124 through catheter 122.


Implant 140 is typically (1) advanceable through inner catheter 124 in a delivery configuration in which adjustment mechanism 146 is disposed on an axis defined by sleeve 142, distally to a distal end 143 of the sleeve, and (2) transitionable into an anchoring configuration in which the adjustment mechanism is disposed laterally to the sleeve (FIG. 3A shows implant 140 in the anchoring configuration thereof). Advancement of implant 140 distally out of catheter 14 is typically controllable using a third handle 132 which is slidably coupled to handle 128, e.g., via a handle-sliding track 138.


A portion of sleeve 142 (e.g., distal end 143) is placed against annulus 10 (FIG. 3A). Typically, system 120 further comprises an implant-decoupling channel 130, disposed within sleeve 142, and slidable progressively proximally out of the sleeve, e.g., using a knob 134 coupled to a proximal end of channel 130. Typically, channel 130 is used to hold the portion of sleeve 142 (e.g., distal end 143) against annulus 10.



FIG. 3A shows anchor driver 60 (e.g., anchor-engaging head 62 thereof) being coupled to a first anchor 40 (not visible in FIG. 3A) which is disposed within a first housing 22 of device 100, as described hereinabove (e.g., with reference to FIGS. 1A-C). Subsequently, as shown in FIG. 3B, anchor driver 60 is withdrawn from the first housing 22 of device 100, while coupled to anchor 40. Anchor 40 is then advanced into system 120 by advancing driver 60 (e.g., anchor-engaging head 62 and shaft 64 thereof) through the system (FIG. 3C). Typically, and as shown in FIG. 3C, the anchor is introduced into system 120 via a port 136 at a proximal end of handle 132, and is slid through channel 130, into sleeve 142, and is screwed through sleeve 142 (e.g., distal end 143 thereof) and into annulus 10.


Driver 60 is subsequently removed from system 120, coupled to a second anchor 40 disposed in a second housing 22 of device 100, and reintroduced into the system. Channel 130 is withdrawn slightly proximally from the sleeve, and a second portion of the sleeve is held against a second site on annulus 10 before the second anchor is driven through sleeve 142, anchoring the second portion of the sleeve to the second site. This process is repeated so as to place and anchor sleeve 142 around at least a portion of annulus 10.


Typically, and as shown in FIGS. 3A-C, device 100 is coupled to system 120 (e.g., the rest of system 120) so as to facilitate access by driver 60 to openings 28 of channels 24 of housings 22. For example, device 100 may be coupled to a stand (e.g., a base-plate) 121 of system 120, and/or may be oriented such that openings 28 face generally the same direction as port 136 of system 120, such that the operator (e.g., a physician) may easily move driver 60 between openings 28 and port 136. Typically, device 100 is positioned such that openings 28 are closer than 1 m and/or greater than 1 cm (e.g., between 1 cm and 1 m, such as between 1 cm and 70 cm, such as between 1 cm and 40 cm) away from port 136 (or another opening through which anchors 40 are introduced into system 120).


Alternatively, device 100 may comprise a standalone unit, not coupled to system 120 or any other system.


Subsequently, implant 140 may be adjusted (e.g., contracted) using an adjustment tool (not shown), advanceable over a guide member 141 to adjustment mechanism 146.


Reference is made to FIGS. 4A-F, which are schematic illustrations of an anchor-handling device 220, configured to facilitate handling of at least one tissue anchor 40, in accordance with some applications of the invention. Device 220 comprises a housing 222 that defines a channel 224 having an anchor-storage zone 226 and an opening 228 that provides access to the channel and the anchor-storage zone. Device 220 further comprises a retaining member, such as a pin 230, which is configured to retain tissue anchor 40 in zone 226, and to stop retaining the tissue anchor in response to a sufficient proximally-directed force applied to the tissue anchor. That is, when a proximally-directed force that is greater than a pre-determined threshold force is applied to tissue anchor 40, the retaining member stops retaining (e.g., releases) the tissue anchor. For some applications FIGS. 4A-F, which show steps in the use of device 220, generally correspond to FIGS. 1A-F, respectively, which show steps in the use of device 20, mutatis mutandis.


Typically, the retaining member (e.g., pin 230) has a retaining state in which it retains tissue anchor 40 within zone 226, and is moved out the retaining state when the sufficient proximally-directed force is applied to the tissue anchor. FIG. 4A shows, in accordance with some applications of the invention, pin 230 in a retaining state thereof, in which at least a portion 229 (e.g., an obstructing portion) of the pin is disposed within channel 224 (e.g., proximal to anchor 40), thereby retaining the anchor in zone 226 by obstructing proximal movement of the tissue anchor. Typically, portion 229 obstructs proximal movement of anchor 40 by engaging and/or obstructing core 41 of the anchor. Another portion of pin 230 is disposed in a chamber 274, which is defined by housing 222 and is typically in fluid communication with channel 224 (e.g., in the absence of pin 230). Typically, chamber 274 has a central longitudinal axis ax1 that is parallel with a central longitudinal axis ax2 of channel 24.


Similarly to device 20, it is hypothesized that this configuring of device 220 prevents inadvertent movement and/or exit of the tissue anchor (e.g., due to general transport or handling of the device), and/or withdrawal of the anchor by driver 60 when the driver is sub-optimally coupled to the anchor.



FIG. 4A shows anchor driver 60 (described hereinabove) being advanced toward opening 228 of channel 224, and FIG. 4B shows the anchor driver having been further advanced into and through channel 224, to anchor 40, such that engaging head 62 has received anchor 40, but not yet coupled (e.g., locked) to the anchor. It is to be noted that in this position part of driver 60 (e.g., head 62) is disposed (e.g., sandwiched) between part of the retaining member (e.g., portion 229) and part of the anchor (e.g., coupling head 42).



FIG. 4A shows respective cross-sections of opening 228 and driver head 62, which are typically each rotationally asymmetrical. For some applications, and as shown, the cross-sections each have the shape of an ellipse (e.g., a circle) with a segment (e.g., a circular segment) removed. (For some applications opening 228 (e.g., the shape thereof) is defined partly by housing 222, and partly by pin 230.) Due to this rotational asymmetry, anchor-engaging head 62 is introducible through opening 228 in fewer than all rotational orientations of the head with respect to the opening. For example, head 62 may be introducible through opening 228 only in one or more particular rotational orientations (e.g., one particular orientation of the head) of the head with respect to the opening. This limitation of the rotational orientations in which head 62 may be introduced through opening 228 causes the head to be correctly rotationally oriented for coupling to coupling head 42 of anchor 40, the anchor being stored in zone 226 in a given rotational orientation with respect to the opening. Therefore anchor-engaging head 62 is couplable to anchor 40, without rotating the anchor-engaging head subsequently to introducing the anchor-engaging head through opening 228.


It is to be noted that this orientation-limitation may be applied to device 20, mutatis mutandis, and that the lateral channel opening that provides region 25 of device 20 may be applied to device 220, mutatis mutandis.



FIG. 4C shows wire 72 having been moved distally into engaging head 62, and detent 70 having been pushed into the closed state, thereby coupling the engaging head to anchor 40 (e.g., to coupling head 42 thereof).



FIGS. 4D-E show anchor 40 being withdrawn proximally from zone 226 by the sufficient proximally-directed force being applied to the anchor by driver 60. As described hereinabove, in response to the sufficient proximally-directed force applied to the tissue anchor (i.e., if the proximally-directed force is greater than the pre-determined threshold force), the retaining member (e.g., pin 230) stops retaining the tissue anchor in zone 226. For example, and as shown in FIGS. 4D-E, the sufficient proximally-directed force overcomes the retention provided by pin 230 such that at least a portion of pin 230 slides within chamber 274, and at least a portion 231 (e.g., a proximal portion) of pin 230 moves out of housing 222.



FIG. 4D shows portion 231 of pin 230 beginning to move out of housing 222, and FIG. 4E shows both portion 231 and anchor 40 disposed outside of the housing, such that pin 230 (e.g., portion 229 thereof) no longer obstructs anchor 40. It is to be noted that for device 220, the portion 229 of pin 230 that obstructs anchor 40 is disposed close to (e.g., within) the portion 231 of pin 230 that becomes exposed from housing 222, whereas for device 20 described hereinabove, the portion 29 of pin 30 that obstructs anchor 40 is disposed at another part (e.g., at the other end) of pin 30 from the portion 31 of pin 30 that becomes exposed from housing. Similarly, portion 229 typically becomes exposed from housing 222 upon withdrawal of anchor 40 from device 20, whereas portion 29 typically remains within housing 22 upon withdrawal of anchor 40 from device 220.



FIG. 4F shows anchor 40 having been fully removed from the housing. For some applications, to facilitate full disengagement of anchor 40 from pin 230, the anchor is moved slightly laterally with respect to pin 30. Once anchor 40 has been fully withdrawn, driver 60 may be used to anchor tissue anchor 40 to tissue of a subject, e.g., as described hereinabove.


Device 220 comprises an inhibitor, configured to configure the retaining member (e.g., pin 30) to (i) retain the tissue anchor in anchor-storage zone 26, and (ii) to stop retaining the tissue anchor in response to the sufficient proximally-directed force. For example, pin 230 may comprise or define a detent 282 that, while anchor 40 is disposed within anchor-storage zone 226, is held by a spring mechanism within a cavity 232 (e.g., a notch) defined in chamber 274, and thereby serves as the inhibitor. For some applications at least a portion 280 of pin 230 is resilient, and thereby provides the spring mechanism. It is to be noted, however, that the scope of the invention includes the use of other spring mechanisms. The inhibitor provides resistance that (i) inhibits sliding of pin 230 through chamber 274, e.g., prevents sliding of the pin in the absence of a sufficient proximally-directed force (e.g., as shown in FIG. 4C), and (ii) stops inhibiting the sliding in response to the sufficient proximally-directed force by detent 282 moving out of cavity 232 (e.g., as shown in FIG. 4D). For example, and as shown, resilient portion 280 deforms (e.g., bends) in response to the sufficient proximally-directed force. This is typically facilitated by detent 282 and a proximal wall of cavity 232 having respective faces that are appropriately angled with respect to each other such that the proximally-directed force is converted into lateral movement of the detent out of the cavity. For example, and as shown, detent 282 may have a beveled edge.


Typically, for such applications, once detent 282 has moved out of cavity 232, a proximally-directed force that is smaller than the threshold force is sufficient to move pin 30 further proximally. That is, once the initial resistance provided by the inhibitor is overcome, anchor 40 is further withdrawable using a smaller force than that required to overcome the initial resistance.


(It will be understood by those skilled in the art that it is possible to use other configurations to achieve a behavior similar to that described above. For example, housing 222 may define a protrusion (e.g., a detent), and pin 30 may comprise a cavity (e.g., a notch) into which the protrusion extends.)


For some applications, the inhibitor provides the resistance by applying friction against the wall of cavity 232. For example, pin 230 may have a high-friction wall-contacting surface.


Device 220 is described hereinabove with reference to only one channel 224, zone 226, and restraining member. Typically however, the device defines a plurality of channels 224, each channel having a respective proximal opening 228 and a respective anchor-storage zone 226 that is configured to store a respective tissue anchor 40 (e.g., as described with reference to device 100, mutatis mutandis). Typically, device 220 further comprises a plurality of retaining members (e.g., pins 230), each retaining member being configured to retain a respective tissue anchor in its respective anchor-storage zone 226, and to stop retaining the respective tissue anchor in response to the sufficient proximally-directed force being applied to its respective tissue anchor.


As described hereinabove, for some applications, the sufficient proximally-directed force pushes portion 231 of pin 30 out of housing 222. Therefore, as driver 60 is withdrawn proximally, movement of portion 231 out of housing 222 indicates that anchor-engaging head 62 has been successfully coupled to tissue anchor 40, and that the tissue anchor is also being withdrawn proximally. Thus, during an initial partial withdrawal of driver 60, movement of portion 231 out of housing 222 provides an indication to the operator (e.g., physician) to continue to withdraw driver 60, whereas absence of such movement of portion 231 provides an indication to the operator to reattempt coupling of the driver to tissue anchor 40.


Following removal of anchor 40 from channel 224, portion 231 remains exposed outside of housing 222. This may be particularly useful for a physician using device 220, e.g., to prevent the physician inadvertently attempting to obtain an anchor from an empty anchor-storage zone 226. That is, portion 231 functions as an empty-housing indicator.


For some applications, a second cavity 234 is defined in chamber 274 (e.g., a second notch in a wall of the chamber), disposed more proximally with respect to housing 222 than is cavity 232. Second cavity 234 is positioned such that when (1) portion 229 is no longer obstructing anchor 40, and (2) portion 231 is exposed out of opening 278, detent 282 (i.e., the inhibitor) moves into the second cavity (e.g., as shown in FIG. 4E). In this state, the detent inhibits pin 230 from moving distally back into housing 222, thereby increasing the reliability of portion 31 functioning as an empty-housing indicator.


For some applications, and as shown in FIGS. 1A-F, second cavity 234 is dimensioned and/or shaped such that once detent 282 has moved into (e.g., engaged) second cavity 234, a distally-directed force required to return portion 231 into housing 222 (e.g., to return device 220 into its retaining state) is more than twice as great (in the opposite direction) as the threshold force that was previously required to move portion 231 out of the housing, and to remove anchor 40 from the housing. For example, and as shown, cavity 234 may be greater in one or more dimensions (e.g., wider and/or deeper) than cavity 232. While detent 282 is disposed in cavity 232, the beveled edge of the detent is partly exposed from cavity 232, whereas while the detent is disposed in cavity 234, the beveled edge is disposed entirely within the cavity. Other geometric configurations may also be used to generate this effect. For example, only a proximal face of detent 282 may be beveled.


For some applications, housing 222 is at least in part transparent, so as to enable viewing of the coupling of driver 60 to anchor 40, and/or withdrawal of the anchor from the housing.


Reference is made to FIGS. 5A-C, which are schematic illustrations of a base 300 to which device 220 (e.g., housing 222 thereof) is couplable, and which is configured to at least partly immobilize the housing, in accordance with some applications of the invention. For some applications, and as shown, more than one device 220 is couplable to base 300. Similarly to devices 20 and 100, for some applications device 220 is used with multi-component tubular system 120 (described hereinabove). For such applications, anchor driver 60 (e.g., anchor-engaging head 62 thereof) is coupled to an anchor 40, and then advanced into system 120 (e.g., via a port 136 at a proximal end of handle 132). As described hereinabove, shaft 64 is flexible, and typically has a length greater than 20 cm, and/or less than 2.5 m, such as greater than 50 cm and/or less than 1.5 m, e.g., between 0.9 m and 1.2 m. Because of this flexibility and length, it may be difficult for an operator (e.g., a physician) to wield and operate handle driver 60 (e.g., to couple head 62 to an anchor while retaining control of shaft 64 and handle 66). Base 300 facilitates such handling by defining a handle receptacle 302 for housing and at least partly immobilizing handle 66.


Typically, base 300 is configured such that when device 220 (e.g., housing 222 thereof) is coupled to the base, the housing is disposed less than 30 cm from receptacle 302 (e.g., less than 20 cm, e.g., less than 10 cm, such as less than 5 cm from the receptacle), and therefore less than 30 cm from handle 66 when the handle is disposed in the receptacle. Because shaft 64 is typically flexible, despite its length typically being greater than (e.g., more than twice as great, e.g., more than 5 times as great, such as 2-10 times as great as) the distance between device 220 and receptacle 302, driver head 62 is insertable into device 220 while handle 66 is disposed in receptacle 302.


For some applications, device 220 is permanently coupled to base 300 (e.g., device 220 and base 330 may be integrated). For some applications device 220 is reversibly couplable to base 300. For example, base 300 may further define at least one housing receptacle 304, configured to house device 220. For such applications, base 300 further comprises a locking element 306, movable between a locked state that locks the housing within the receptacle, and an unlocked state that facilitates release of the housing from the receptacle. For example, and as shown, locking element 306 may comprise one or more bars 308 that are advanceable through a portion of base 300 so as to protrude into (e.g., through) receptacle 304; and housing 222 is shaped to define a respective one or more recesses 310 dimensioned to mate with the bars. Advancing bars 308 into receptacle 304 while housing 222 is disposed in the receptacle thereby locks the housing within the receptacle.


Typically, receptacle 302 is dimensioned such that adjuster 68 is operable while the receptacle houses handle 66. This, along with the proximity of handle 66 to device 220, advantageously facilitates the operator (i) with a first hand, grasping a distal portion of driver 60 and introducing driver head 62 into the opening of housing 222, and (ii) with a second hand, reversibly actuating driver head 62 by operating the adjuster while grasping the distal portion of the driver with the first hand (FIG. 5C; operator's hands not shown). It is hypothesized that this advantageously improves wielding and operation of driver 60 in combination with device 220.


For some applications, base 300 is coupled to system 120, e.g., as described hereinabove for device 100 with respect to FIGS. 3A-C, mutatis mutandis.


For some applications, base 300 does not define a handle receptacle, but instead serves only to hold device 220.


For some applications, device 20, device 100, and/or device 220 is used in combination with one or more techniques described in one or more of the following references, which are all incorporated herein by reference:

    • U.S. patent application Ser. No. 12/437,103 to Zipory et al., filed May 7, 2009, which published as U.S. 2010/0286767. For example, (1) device 100 of the present application may be used to facilitate the techniques described with reference to FIGS. 2-3 and/or 6A-12 of U.S. 2010/0286767 to Zipory et al., mutatis mutandis; (2) anchor driver 60 of the present application may comprise or correspond to anchor driver 68 and/or anchor deployment manipulator 24 of U.S. 2010/0286767 to Zipory et al., mutatis mutandis; (3) tissue anchor 40 of the present application may comprise or correspond to anchor 38 of U.S. 2010/0286767 to Zipory et al., mutatis mutandis; and/or (4) implant 140 of the present application may comprise or correspond to annuloplasty ring 22 of U.S. 2010/0286767 to Zipory et al., mutatis mutandis.
    • U.S. patent application Ser. No. 12/689,635 to Zipory et al., filed Jan. 19, 2010, which published as U.S. 2010/0280604. For example, (1) device 100 of the present application may be used to facilitate the techniques described with reference to FIGS. 2-3 and/or 11A-17 of U.S. 2010/0280604 to Zipory et al., mutatis mutandis; (2) anchor driver 60 of the present application may comprise or correspond to anchor driver 68 and/or anchor deployment manipulator 24 of U.S. 2010/0280604 to Zipory et al., mutatis mutandis; (3) tissue anchor 40 of the present application may comprise or correspond to anchor 38 of U.S. 2010/0280604 to Zipory et al., mutatis mutandis; and/or (4) implant 140 of the present application may comprise or correspond to annuloplasty ring 22 of U.S. 2010/0280604 to Zipory et al., mutatis mutandis.
    • PCT patent application IL2012/050451 to Sheps et al., filed Nov. 8, 2013, which published as WO 2013/069019. For example, (1) device 100 of the present application may be used to facilitate the techniques described with reference to FIGS. 14A-I of WO 2013/069019 to Sheps et al., mutatis mutandis; (2) system 120 of the present application may comprise or correspond to system 10 of WO 2013/069019 to Sheps et al., mutatis mutandis; (3) anchor driver 60 of the present application may comprise or correspond to anchor deployment manipulator 61 and/or anchor driver 36 of WO 2013/069019 to Sheps et al., mutatis mutandis; and/or (4) implant 140 of the present application may comprise or correspond to annuloplasty structure 222 and/or sleeve 26 of WO 2013/069019 to Sheps et al., mutatis mutandis.
    • PCT patent application IL2013/050860 to Sheps et al., titled “Controlled steering functionality for implant-delivery tool”, filed on Oct. 23, 2013, which published as WO 2014/064694. For example, (1) device 100 of the present application may be used to facilitate techniques described with reference to FIGS. 10A-I, 12A-14B, 18A-C, 21-28, 34, and 36 of this PCT application titled “Controlled steering functionality for implant-delivery tool”, mutatis mutandis; (2) system 120 of the present application may comprise or correspond to system 10 of this PCT application titled “Controlled steering functionality for implant-delivery tool”, mutatis mutandis; anchor driver 60 of the present application may comprise or correspond to anchor deployment manipulator 61, anchor driver 36 and/or anchor driver 2338 of this PCT application titled “Controlled steering functionality for implant-delivery tool”, mutatis mutandis; and/or (4) implant 140 of the present application may comprise or correspond to annuloplasty structure 222 and/or sleeve 26 of this PCT application titled “Controlled steering functionality for implant-delivery tool”, mutatis mutandis.
    • PCT patent application IL2013/050861 to Herman et al., titled “Percutaneous tissue anchor techniques”, filed on Oct. 23, 2013, which published as WO 2014/064695. For example, (1) device 100 of the present application may be used to facilitate the techniques described with reference to FIGS. 9A-C and/or 13A-D of this PCT application titled “Percutaneous tissue anchor techniques”, mutatis mutandis; (2) tissue anchor 40 of the present application may comprise or correspond to tissue anchor 40 of this PCT application titled “Percutaneous tissue anchor techniques”, mutatis mutandis; and/or (3) anchor driver 60 of the present application may comprise or correspond to anchor driver 500, anchor driver 236, deployment manipulator 261, or tool 80 of this PCT application titled “Percutaneous tissue anchor techniques”, mutatis mutandis.


Reference is again made to FIGS. 1A-5C. Typically, the tissue anchor is dimensioned to fit snugly in the anchor-storage zone of the housing. Typically, the tissue anchor (e.g., core 41 thereof) is dimensioned to slide snugly through the channel of the housing, and for some applications this snug sliding prevents tissue-engaging member 44 of the anchor from touching the housing (e.g., the wall of the channel) when the anchor moves through the channel. Typically, at least a portion of the pin is dimensioned to slide snugly through the chamber.


As described hereinabove, for some applications the obstructing portion of the retaining member of devices 20 and 220 obstructs tissue anchor 40 by engaging core 41 of the anchor. The movement of the retaining member in response to the proximally-directed force applied to the anchor typically moves the obstructing portion such that it does not subsequently engage tissue-engaging member 44 of the anchor. For example, for device 20, portion 29 moves at least partly laterally out of the anchor-storage zone and/or channel 24 (such that element 44 can move past portion 29 without being engaged by it), and for device 220, portion 229 moves longitudinally out of channel 224 (such that element 44 can move past portion 229 without being engaged by it). It is hypothesized that for some applications this advantageously reduces a likelihood of the anchor-handling device (e.g., the obstructing portion of the retaining member) damaging tissue-engaging member 44. It is hypothesized that the use of a retaining member that has an obstructing portion that returns to its original position as soon as core 41 has moved past the obstructing portion, does not have this advantageous feature.


It is to be noted that the technique used to inhibit movement of the retaining member of device 20 may be used to inhibit movement of the retaining member of device 220, mutatis mutandis, and vice versa.


Reference is again made to FIGS. 1A-5C. It is to be noted that, for both device 20 and device 220, proximal withdrawal of anchor 40 typically results in sliding of the retaining member (e.g., the pin) in an at least partly proximal direction. This sliding is typically along an axis that is disposed at and angle of less than 30 degrees with respect to a central longitudinal axis of the channel through which the anchor is withdrawn. For example, for device 20 the angle is typically 8-30 degrees (e.g., 10-20 degrees, such as 11-14 degrees), and for device 220 the angle is typically less than 10 degrees, such as 0 degrees—i.e., parallel with the channel.


Reference is again made to FIGS. 1A-5C. As described hereinabove, the anchor-handling devices allow retrieval of the tissue anchor(s) disposed therein in response to a proximally-directed force that is greater than a threshold force. Typically the threshold force is greater than 300 grams force and/or less than 1500 grams force (e.g., 300-1500 grams force, e.g., 500-1200 grams force, e.g., 500-1000 grams force, such as 600-800 grams force). Tissue anchor 40 typically has a mass of less than 1 g and/or greater than 0.01 g (e.g., 0.01-1 g, e.g., 0.05-0.2 g, e.g., 0.07-0.12 g, such as about 0.1 g). Thus the threshold force (measured in grams force) is typically greater than 300 times (e.g., greater than 1000 times, e.g., greater than 3000 times, e.g., greater than 10,000 times, such as greater than 15,000 times) and/or less than 150,000 times the mass of the tissue anchor (measured in grams). It is to be noted that the threshold force is therefore many times greater than that which would be required simply to prevent the tissue anchor from undesirably exiting the device due to gravity and/or movement of the device (e.g., during transport).


This configuration of the anchor-handling device serves to test coupling of the anchor driver to the tissue anchor before releasing the tissue anchor. Only if the coupling is sufficient to support a proximally-directed force that is greater than the threshold force, will the device release the anchor. This is hypothesized to increase safety and reliability of the use of the anchor and driver, e.g., by reducing a likelihood that the anchor will subsequently become disengaged from the driver at an undesired time (e.g., within the body of a subject). Whereas one might consider testing the anchor-driver coupling subsequently to removal of the anchor from the anchor-handling device, such post-removal testing requires an extra procedural step, and for some applications it increases a likelihood of damaging and/or contamination of the (typically sterile) tissue anchor. Furthermore, whereas the anchor-handling devices described herein facilitate making a second attempt at coupling the driver to the same anchor, post-removal testing typically does not.


Reference is again made to FIGS. 1A-5C. Typically the anchors are provided sterile within the anchor-handling device. As described hereinabove, for some applications, the anchor-handling device is configured such that returning the exposed portion of the retaining member back into the housing requires a distally-directed force that is more than twice as great (in the opposite direction) as the threshold force that was previously required to move the portion out of the housing. For example, the moving of the portion back into the housing may be in effect prevented. As well as facilitating the exposed portion serving as an empty-housing indicator, this characteristic of the anchor-handling device discourages and/or prevents the operator from returning a previously-removed anchor into the device, e.g., thereby ensuring that only sterile anchors are disposed within the device.


For some applications, the anchor-handling devices described herein are configured to be at least in part submerged in saline prior to and/or during use, e.g., to reduce a likelihood of air (e.g., bubbles) being retained by the anchor and/or driver and subsequently introduced into the subject.


It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.

Claims
  • 1. A system comprising: an anchor driver;a housing, shaped to define a channel having an anchor-storage zone and a proximal opening configured to provide access for the anchor driver to the anchor-storage zone;a tissue anchor, stored in the anchor-storage zone and slidable through the channel; anda retaining member: having a retaining state in which the retaining member is configured to retain the tissue anchor in the anchor-storage zone, andbeing configured, by moving in response to a proximally-directed force applied to the tissue anchor, to allow the tissue anchor to leave the anchor-storage zone in response to the proximally-directed force, the proximally-directed force being greater than a pre-determined threshold force;
  • 2. The system according to claim 1, is configured such that after removal of the tissue anchor from the housing, a distally-directed force required to return the retaining member to the retaining state is more than twice as great as the threshold force.
  • 3. The system according to claim 1, wherein the retaining member is configured such that the threshold force is greater than 300 grams force.
  • 4. The system according to claim 1, wherein, in the retaining state, at least a portion of the retaining member obstructs proximal movement of the tissue anchor by being disposed within the channel.
  • 5. The system according to claim 4, wherein in the retaining state, the anchor driver is slidable through the channel and lockable to the tissue anchor while at least the portion of the retaining member obstructs proximal movement of the tissue anchor by being disposed within the channel.
  • 6. The system according to claim 5, wherein in the retaining state, the anchor driver is slidable through the channel such that a part of the anchor driver becomes positioned between a part of the tissue anchor and a part of the retaining member, and the anchor driver is lockable to the tissue anchor only while the part of the anchor driver is positioned between the part of the tissue anchor and the part of the retaining member.
  • 7. The system according to claim 4, wherein: the housing is shaped to define a chamber that is in fluid communication with the channel,at least part of the retaining member is configured to slide within the chamber in response to the proximally-directed force applied to the tissue anchor, andthe retaining member is configured such that, in response to the proximally-directed force applied to the tissue anchor, a second portion of the retaining member moves out of the housing.
  • 8. The system according to claim 7, wherein: the retaining member comprises a pin, configured to slide through the chamber,the housing is shaped to define a chamber that is in fluid communication with the channel,at least part of the retaining member is configured to slide within the chamber in response to the proximally-directed force applied to the tissue anchor,the housing is shaped to define a cavity that is in fluid communication with the chamber,at least a portion of the retaining member is resilient,the retaining member is shaped to define a detent,in the retaining state, the resilience of at least the portion of the retaining member holds the detent within the cavity, andthe retaining member is configured to deform in response to the proximally-directed force applied to the tissue anchor, such that the detent exits the cavity.
  • 9. The system according to claim 8, wherein: the cavity comprises a first cavity,the housing is shaped to define a second cavity that is in fluid communication with the chamber, andthe system is dimensioned such that when the retaining member allows the tissue anchor to leave the anchor-storage zone, further proximal movement of the retaining member causes the detent to move into the second cavity.
  • 10. The system according to claim 9, wherein the second cavity is larger in at least one dimension than the first cavity.
  • 11. The system according to claim 9, wherein the second cavity is differently shaped to the first cavity.
  • 12. The system according to claim 9, wherein the second cavity and the detent are dimensioned such that when the detent is disposed within the second cavity, a distally-directed force required to return the retaining member to the retaining state is more than twice as great as the threshold force.
  • 13. The system according to claim 7, wherein the chamber is in fluid communication with the channel at a distal end of the chamber, and has a proximal-distal longitudinal axis that is disposed at between 5 and 30 degrees from a proximal-distal longitudinal axis of the channel.
  • 14. The system according to claim 4, wherein: the housing is shaped to define a chamber that is in fluid communication with the channel,at least part of the retaining member is configured to slide within the chamber in response to the proximally-directed force applied to the tissue anchor, anda central longitudinal axis of the chamber is parallel with a central longitudinal axis of the channel.
  • 15. The system according to claim 1, wherein the anchor driver comprises: at a distal end thereof, an anchor-engaging head introducible through the opening of the housing and actuatable to be reversibly coupled to the tissue anchor;at a proximal end thereof, a handle comprising an adjuster configured to actuate the anchor-engaging head; anda flexible shaft: disposed between the distal end of the anchor driver and the proximal end of the anchor driver,having a length of 50-250 cm, andconfigured to be transcatheterally advanced through vasculature of a subject.
  • 16. The system according to claim 15, wherein the opening of the housing is rotationally asymmetrical, a transverse cross-section of the anchor-engaging head is rotationally asymmetrical, and the opening limits a range of rotational orientations of the anchor-engaging head with respect to the opening in which the anchor-engaging head is introducible through the opening.
  • 17. The system according to claim 16, wherein the tissue anchor is stored in the anchor-storage zone in a given rotational orientation of the tissue anchor with respect to the opening, the anchor-engaging head is couplable to the tissue anchor in not all rotational orientations of the head with respect to the tissue anchor, and the anchor-engaging head is couplable to the tissue anchor without rotating the anchor-engaging head subsequently to introducing the anchor-engaging head through the opening.
  • 18. The system according to claim 16, wherein the opening limits the range of rotational orientations such that the anchor-engaging head is introducible through the opening in only a given rotational orientation of the head with respect to the opening.
  • 19. The system according to claim 15, further comprising a base, wherein: the housing is couplable to the base,the base is configured to at least partly immobilize the housing, andthe base is shaped to define a receptacle for housing and at least partly immobilizing the handle such that the adjuster remains operable.
  • 20. The system according to claim 19, wherein when the housing is coupled to the base, the housing is disposed less than 30 cm from the receptacle.
  • 21. A system comprising: an anchor driver;a housing, shaped to define a channel having an anchor-storage zone and a proximal opening configured to provide access for the anchor driver to the anchor-storage zone;a tissue anchor, stored in the anchor-storage zone and slidable through the channel; anda retaining member: having a retaining state in which the retaining member is configured to retain the tissue anchor in the anchor-storage zone,being configured, by moving in response to a proximally-directed force applied to the tissue anchor, to allow the tissue anchor to leave the anchor-storage zone in response to the proximally-directed force, the proximally-directed force being greater than a pre-determined threshold force, andbeing configured such that the threshold force is greater than 300 grams force.
  • 22. The system according to claim 21, wherein the tissue anchor has a mass, and the retaining member is configured such that the threshold force, measured in grams force, is more than 1000 times greater than the mass of the tissue anchor, measured in grams.
  • 23. A system comprising: an anchor driver;a housing, shaped to define a channel having an anchor-storage zone and a proximal opening configured to provide access for the anchor driver to the anchor-storage zone;a tissue anchor, stored in the anchor-storage zone and slidable through the channel; anda retaining member: having a retaining state in which the retaining member is configured to retain the tissue anchor in the anchor-storage zone, andbeing configured, by moving in response to a proximally-directed force applied to the tissue anchor, to allow the tissue anchor to leave the anchor-storage zone in response to the proximally-directed force, the proximally-directed force being greater than a pre-determined threshold force,
  • 24. The system according to claim 23, wherein the retaining member is configured such that the threshold force is greater than 300 grams force.
  • 25. The system according to claim 23, wherein the tissue anchor has a mass, and the retaining member is configured such that the threshold force, measured in grams force, is more than 1000 times greater than the mass of the tissue anchor, measured in grams.
  • 26. The system according to claim 23, wherein: the cavity comprises a first cavity,the housing is shaped to define a second cavity that is in fluid communication with the chamber, andthe system is dimensioned such that when the retaining member allows the tissue anchor to leave the anchor-storage zone, further proximal movement of the retaining member causes the detent to move into the second cavity.
  • 27. The system according to claim 26, wherein the second cavity is larger in at least one dimension than the first cavity.
  • 28. The system according to claim 26, wherein the second cavity is differently shaped to the first cavity.
  • 29. The system according to claim 26, wherein the second cavity and the detent are dimensioned such that when the detent is disposed within the second cavity, a distally-directed force required to return the retaining member to the retaining state is more than twice as great as the threshold force.
  • 30. A system comprising: an anchor driver;a housing, shaped to define a channel having an anchor-storage zone and a proximal opening configured to provide access for the anchor driver to the anchor-storage zone;a tissue anchor, stored in the anchor-storage zone and slidable through the channel; anda retaining member: having a retaining state in which the retaining member is configured to retain the tissue anchor in the anchor-storage zone, andbeing configured, by moving in response to a proximally-directed force applied to the tissue anchor, to allow the tissue anchor to leave the anchor-storage zone in response to the proximally-directed force, the proximally-directed force being greater than a pre-determined threshold force,
CROSS-REFERENCES TO RELATED APPLICATIONS

The present application is a US National Phase of PCT application IL2014/050914 to Zipory et al., which published as WO 2015/059699, and which claims priority from US Provisional Patent Application U.S. 61/894,486 to Zipory et al., entitled “Anchor Magazine”, filed Oct. 23, 2013, which is incorporated herein by reference. The present application is related to PCT Patent Application IL2013/050861 to Herman et al., entitled “Percutaneous tissue anchor techniques”, filed on Oct. 23, 2013, which published as WO 2014/064695, and PCT Patent Application IL2013/050860 to Sheps et al., entitled “Controlled steering functionality for implant-delivery tool”, filed on Oct. 23, 2013, which published as WO 2014/064694, both of which are incorporated herein by reference.

PCT Information
Filing Document Filing Date Country Kind
PCT/IL2014/050914 10/21/2014 WO 00
Publishing Document Publishing Date Country Kind
WO2015/059699 4/30/2015 WO A
US Referenced Citations (838)
Number Name Date Kind
3604488 Wishart Sep 1971 A
3656185 Carpentier Apr 1972 A
3840018 Heifetz Oct 1974 A
3881366 Bradley et al. May 1975 A
3898701 La Russa Aug 1975 A
4042979 Angell Aug 1977 A
4118805 Reimels Oct 1978 A
4214349 Munch Jul 1980 A
4261342 Aranguren Duo Apr 1981 A
4290151 Massana Sep 1981 A
4434828 Trincia Mar 1984 A
4473928 Johnson Oct 1984 A
4602911 Ahmadi et al. Jul 1986 A
4625727 Leiboff Dec 1986 A
4712549 Peters et al. Dec 1987 A
4778468 Hunt et al. Oct 1988 A
4917698 Carpenter et al. Apr 1990 A
4961738 Mackin Oct 1990 A
5061277 Carpentier et al. Oct 1991 A
5064431 Gilbertson et al. Nov 1991 A
5104407 Lam et al. Apr 1992 A
5108420 Marks Apr 1992 A
5201880 Wright Apr 1993 A
5258008 Wilk Nov 1993 A
5300034 Behnke Apr 1994 A
5306296 Wright et al. Apr 1994 A
5325845 Adair Jul 1994 A
5346498 Greelis et al. Sep 1994 A
5450860 O'Connor Sep 1995 A
5477856 Lundquist Dec 1995 A
5593424 Northrup, III Jan 1997 A
5601572 Middleman Feb 1997 A
5626609 Zvenyatsky et al. May 1997 A
5669919 Sanders et al. Sep 1997 A
5674279 Wright et al. Oct 1997 A
5683402 Cosgrove et al. Nov 1997 A
5702397 Goble et al. Dec 1997 A
5702398 Tarabishy Dec 1997 A
5709695 Northrup, III Jan 1998 A
5716370 Williamson et al. Feb 1998 A
5716397 Myers Feb 1998 A
5728116 Rosenman Mar 1998 A
5730150 Peppel et al. Mar 1998 A
5749371 Zadini et al. May 1998 A
5810882 Bolduc Sep 1998 A
5824066 Gross Oct 1998 A
5830221 Stein et al. Nov 1998 A
5843120 Israel et al. Dec 1998 A
5855614 Stevens et al. Jan 1999 A
5876373 Giba et al. Mar 1999 A
5935098 Blaisdell Aug 1999 A
5957953 DiPoto Sep 1999 A
5961440 Schweich et al. Oct 1999 A
5961539 Northrup, III et al. Oct 1999 A
5984959 Robertson Nov 1999 A
6042554 Rosenman Mar 2000 A
6045497 Schweich et al. Apr 2000 A
6050936 Schweich et al. Apr 2000 A
6059715 Schweich et al. May 2000 A
6074401 Gardiner et al. Jun 2000 A
6074417 Peredo Jun 2000 A
6102945 Campbell Aug 2000 A
6106550 Magovern Aug 2000 A
6110200 Hinnenkamp Aug 2000 A
6143024 Campbell Nov 2000 A
6159240 Sparer Dec 2000 A
6165119 Schweich et al. Dec 2000 A
6174332 Loch Jan 2001 B1
6183411 Mortier Feb 2001 B1
6187040 Wright Feb 2001 B1
6315784 Djurovic Feb 2001 B1
6217610 Carpentier Apr 2001 B1
6231602 Carpentier May 2001 B1
6251092 Qin et al. Jun 2001 B1
6296656 Bodluc et al. Oct 2001 B1
6319281 Patel Nov 2001 B1
6332893 Mortier et al. Dec 2001 B1
6355030 Aldrich et al. Mar 2002 B1
6368348 Gabbay Apr 2002 B1
6402780 Williamson, IV Jun 2002 B2
6406420 McCarthy et al. Jun 2002 B1
6406493 Tu Jun 2002 B1
6419696 Ortiz et al. Jul 2002 B1
6451054 Stevens Sep 2002 B1
6461366 Seguin Oct 2002 B1
6470892 Forsell Oct 2002 B1
6503274 Howanec Jan 2003 B1
6524338 Gundry Feb 2003 B1
6533772 Sherts et al. Mar 2003 B1
6537314 Langberg et al. Mar 2003 B2
6547801 Dargent Apr 2003 B1
6554845 Fleenor Apr 2003 B1
6564805 Garrison et al. May 2003 B2
6565603 Cox May 2003 B2
6569198 Wilson et al. May 2003 B1
6579297 Bicek et al. Jun 2003 B2
6589160 Schweich et al. Jul 2003 B2
6602288 Cosgrove Aug 2003 B1
6602289 Colvin et al. Aug 2003 B1
6613078 Barone Sep 2003 B1
6613079 Wolinsky et al. Sep 2003 B1
6619291 Hlavka et al. Sep 2003 B2
6626899 Houser et al. Sep 2003 B2
6626917 Craig Sep 2003 B1
6626930 Allen et al. Sep 2003 B1
6629534 St. Goar et al. Oct 2003 B1
6629921 Schweich et al. Oct 2003 B1
6651671 Donlon et al. Nov 2003 B1
6652556 VanTasel Nov 2003 B1
6682558 Tu et al. Jan 2004 B2
6689125 Keith et al. Feb 2004 B1
6689164 Seguin Feb 2004 B1
6695866 Kuehn et al. Feb 2004 B1
6702826 Liddicoat et al. Mar 2004 B2
6702846 Mikus et al. Mar 2004 B2
6706065 Langberg Mar 2004 B2
6709385 Forsell Mar 2004 B2
6709456 Langberg et al. Mar 2004 B2
6711444 Koblish Mar 2004 B2
6718985 Hlavka et al. Apr 2004 B2
6719786 Ryan Apr 2004 B2
6723038 Schroeder et al. Apr 2004 B1
6726716 Marquez Apr 2004 B2
6726717 Alfieri et al. Apr 2004 B2
6730121 Ortiz et al. May 2004 B2
6749630 McCarthy et al. Jun 2004 B2
6752813 Goldfarb et al. Jun 2004 B2
6764310 Ichihashi et al. Jul 2004 B1
6764510 Vidlund et al. Jul 2004 B2
6764810 Ma et al. Jul 2004 B2
6770083 Seguin Aug 2004 B2
6786924 Ryan et al. Sep 2004 B2
6786925 Schoon Sep 2004 B1
6790231 Liddicoat Sep 2004 B2
6797001 Mathis Sep 2004 B2
6797002 Spence et al. Sep 2004 B2
6802319 Stevens et al. Oct 2004 B2
6805710 Bolling et al. Oct 2004 B2
6805711 Quijano et al. Oct 2004 B2
6855126 Flinchbaugh Feb 2005 B2
6858039 McCarthy Feb 2005 B2
6880699 Gallagher Apr 2005 B2
6884250 Monassevitch et al. Apr 2005 B2
6893459 Macoviak May 2005 B1
6908482 McCarthy et al. Jun 2005 B2
6918917 Nguyen et al. Jul 2005 B1
6926730 Nguyen et al. Aug 2005 B1
6960217 Bolduc Nov 2005 B2
6964684 Ortiz Nov 2005 B2
6964686 Gordon Nov 2005 B2
6976995 Mathis Dec 2005 B2
6986775 Morales et al. Jan 2006 B2
6989028 Lashinski et al. Jan 2006 B2
6997951 Solem Feb 2006 B2
7004176 Lau Feb 2006 B2
7011669 Kimblad Mar 2006 B2
7011682 Lashinski et al. Mar 2006 B2
7037334 Hlavka et al. May 2006 B1
7077850 Kortenbach Jul 2006 B2
7077862 Vidlund Jul 2006 B2
7087064 Hyde Aug 2006 B1
7101395 Tremulis Sep 2006 B2
7101396 Artof et al. Sep 2006 B2
7112207 Allen et al. Sep 2006 B2
7118595 Ryan Oct 2006 B2
7125421 Tremulis et al. Oct 2006 B2
7150737 Purdy et al. Dec 2006 B2
7159593 McCarthy Jan 2007 B2
7166127 Spence Jan 2007 B2
7169187 Datta et al. Jan 2007 B2
7172625 Shu et al. Feb 2007 B2
7175660 Cartledge et al. Feb 2007 B2
7186262 Saadat Mar 2007 B2
7186264 Liddicoat Mar 2007 B2
7189199 McCarthy et al. Mar 2007 B2
7192443 Solem Mar 2007 B2
7220277 Arru et al. May 2007 B2
7226467 Lucatero et al. Jun 2007 B2
7226477 Cox Jun 2007 B2
7226647 Kasperchik et al. Jun 2007 B2
7229452 Kayan Jun 2007 B2
7238191 Bachmann Jul 2007 B2
7288097 Seguin Oct 2007 B2
7294148 McCarthy Nov 2007 B2
7297150 Cartledge et al. Nov 2007 B2
7311728 Solem et al. Dec 2007 B2
7311729 Mathis Dec 2007 B2
5474518 Farrer Velazquez Jan 2008 A1
7314485 Mathis Jan 2008 B2
7316710 Cheng et al. Jan 2008 B1
7329279 Haug et al. Feb 2008 B2
7329280 Bolling et al. Feb 2008 B2
7335213 Hyde et al. Feb 2008 B1
7361190 Shoulian Apr 2008 B2
7364588 Mathis Apr 2008 B2
7377941 Rhee May 2008 B2
7390329 Westra et al. Jun 2008 B2
7404824 Webler et al. Jul 2008 B1
7431692 Zollinger et al. Oct 2008 B2
7442207 Rafiee Oct 2008 B2
7452376 Lim et al. Nov 2008 B2
7455690 Cartledge et al. Nov 2008 B2
7485142 Milo Feb 2009 B2
7485143 Webler et al. Feb 2009 B2
7500989 Solem et al. Mar 2009 B2
7507252 Lashinski et al. Mar 2009 B2
7510575 Spenser et al. Mar 2009 B2
7510577 Moaddeb Mar 2009 B2
7527647 Spence May 2009 B2
7530995 Quijano May 2009 B2
7549983 Roue et al. Jun 2009 B2
7559936 Levine Jul 2009 B2
7562660 Saadat Jul 2009 B2
7563267 Goldfarb et al. Jul 2009 B2
7563273 Goldfarb et al. Jul 2009 B2
7569062 Kuehn Aug 2009 B1
7588582 Starksen et al. Sep 2009 B2
7591826 Alferness Sep 2009 B2
7604646 Goldfarb et al. Oct 2009 B2
7608091 Goldfarb et al. Oct 2009 B2
7608103 McCarthy Oct 2009 B2
7618449 Tremulis et al. Nov 2009 B2
7625403 Krivoruchko Dec 2009 B2
7632303 Stalker et al. Dec 2009 B1
7635329 Goldfarb et al. Dec 2009 B2
7635386 Gammie Dec 2009 B1
7655015 Goldfarb et al. Feb 2010 B2
7666204 Thornton Feb 2010 B2
7682319 Martin Mar 2010 B2
7682369 Seguin Mar 2010 B2
7686822 Shayani Mar 2010 B2
7699892 Rafiee Apr 2010 B2
7704269 Goar Apr 2010 B2
7704277 Zakay et al. Apr 2010 B2
7722666 Lafontaine May 2010 B2
7736388 Goldfarb et al. Jun 2010 B2
7748389 Salahieh et al. Jul 2010 B2
7753924 Starksen et al. Jul 2010 B2
7758632 Hojeibane et al. Jul 2010 B2
7780726 Seguin Aug 2010 B2
7871368 Zollinger et al. Jan 2011 B2
7871433 Lattouf Jan 2011 B2
7883475 Dupont et al. Feb 2011 B2
7883538 To et al. Feb 2011 B2
7927370 Webler et al. Apr 2011 B2
7927371 Navia Apr 2011 B2
7942927 Kaye et al. May 2011 B2
7947056 Griego et al. May 2011 B2
7955377 Melsheimer Jun 2011 B2
7988725 Gross Aug 2011 B2
7992567 Hirotsuka Aug 2011 B2
7993368 Gambale et al. Aug 2011 B2
7993397 Lashinski Aug 2011 B2
8012201 Lashinski et al. Sep 2011 B2
8034103 Burriesci Oct 2011 B2
8052592 Goldfarb et al. Nov 2011 B2
8057493 Goldfarb et al. Nov 2011 B2
8062355 Figulla et al. Nov 2011 B2
8070804 Hyde Dec 2011 B2
8070805 Vidlund Dec 2011 B2
8075616 Solem Dec 2011 B2
8100964 Spence Jan 2012 B2
8123800 McCarthy Feb 2012 B2
8123801 Milo Feb 2012 B2
8323334 Deem Feb 2012 B2
8142493 Spence et al. Mar 2012 B2
8142495 Hasenkam Mar 2012 B2
8142496 Berreklouw Mar 2012 B2
8147542 Maisano et al. Apr 2012 B2
8152844 Rao Apr 2012 B2
8163013 Machold Apr 2012 B2
8187299 Goldfarb et al. May 2012 B2
8187324 Webler May 2012 B2
8202315 Hlavka Jun 2012 B2
8206439 Gomez-Duran Jun 2012 B2
8216302 Wilson et al. Jul 2012 B2
8226711 Mortier Jul 2012 B2
8231671 Kim Jul 2012 B2
8241351 Cabiri Aug 2012 B2
8252050 Maisano et al. Aug 2012 B2
8262725 Subramanian Sep 2012 B2
8277502 Miller Oct 2012 B2
8287584 Salahieh Oct 2012 B2
8287591 Keidar Oct 2012 B2
8303608 Goldfarb et al. Nov 2012 B2
8328868 Paul Dec 2012 B2
8333777 Schaller Dec 2012 B2
8343173 Starksen et al. Jan 2013 B2
8343174 Goldfarb Jan 2013 B2
8343213 Salahieh et al. Jan 2013 B2
8349002 Milo Jan 2013 B2
8353956 Miller et al. Jan 2013 B2
8357195 Kuehn Jan 2013 B2
8382829 Call et al. Feb 2013 B1
8388680 Starksen et al. Mar 2013 B2
8393517 Milo Mar 2013 B2
8430926 Kirson Apr 2013 B2
8449599 Chau et al. May 2013 B2
8454686 Alkhatib Jun 2013 B2
8460370 Zakay et al. Jun 2013 B2
8460371 Hlavka et al. Jun 2013 B2
8475491 Milo Jul 2013 B2
8480732 Subramanian Jul 2013 B2
8500800 Maisano et al. Aug 2013 B2
8518107 Tsukashima et al. Aug 2013 B2
8523881 Cabiri Sep 2013 B2
8523940 Richardson Sep 2013 B2
8545553 Zipory Oct 2013 B2
8551161 Dolan Oct 2013 B2
8585755 Chau et al. Nov 2013 B2
8591576 Hasenkam Nov 2013 B2
8608797 Gross Dec 2013 B2
8628569 Benichou et al. Jan 2014 B2
8628571 Hacohen et al. Jan 2014 B1
8641727 Starksen et al. Feb 2014 B2
8652202 Alon et al. Feb 2014 B2
8652203 Quadri et al. Feb 2014 B2
8679174 Ottma et al. Mar 2014 B2
8685086 Navia et al. Apr 2014 B2
8690939 Miller et al. Apr 2014 B2
8715342 Zipory et al. May 2014 B2
8728097 Sugimoto et al. May 2014 B1
8728155 Montorfano et al. May 2014 B2
8734467 Miller et al. May 2014 B2
8740920 Goldfarb et al. Jun 2014 B2
8747463 Fogarty et al. Jun 2014 B2
8778021 Cartledge Jul 2014 B2
8784481 Alkhatib et al. Jul 2014 B2
8790367 Nguyen et al. Jul 2014 B2
8790394 Miller et al. Jul 2014 B2
8795298 Hernlund et al. Aug 2014 B2
8795355 Alkhatib Aug 2014 B2
8795356 Quadri et al. Aug 2014 B2
8795357 Yohanan et al. Aug 2014 B2
8808366 Braido et al. Aug 2014 B2
8808368 Maisano et al. Aug 2014 B2
8808371 Cartledge Aug 2014 B2
8845717 Khairkhahan et al. Sep 2014 B2
8845723 Spence et al. Sep 2014 B2
8852261 White Oct 2014 B2
8852272 Gross et al. Oct 2014 B2
8858623 Miller et al. Oct 2014 B2
8864822 Spence et al. Oct 2014 B2
8870948 Erzberger et al. Oct 2014 B1
8870949 Rowe Oct 2014 B2
8888843 Khairkhahan et al. Nov 2014 B2
8894702 Quadri et al. Nov 2014 B2
8911461 Traynor et al. Dec 2014 B2
8911494 Hammer et al. Dec 2014 B2
8926695 Gross et al. Jan 2015 B2
8926696 Cabin et al. Jan 2015 B2
8926697 Gross et al. Jan 2015 B2
8932343 Alkhatib et al. Jan 2015 B2
8932348 Solem et al. Jan 2015 B2
8940042 Miller et al. Jan 2015 B2
8940044 Hammer et al. Jan 2015 B2
8945211 Sugimoto Feb 2015 B2
8951285 Sugimoto et al. Feb 2015 B2
8951286 Sugimoto et al. Feb 2015 B2
8961595 Alkhatib Feb 2015 B2
8961602 Kovach et al. Feb 2015 B2
8979922 Jayasinghe et al. Mar 2015 B2
9005273 Salahieh et al. Apr 2015 B2
9011520 Miller et al. Apr 2015 B2
9011530 Reich et al. Apr 2015 B2
9017399 Gross et al. Apr 2015 B2
9023100 Quadri et al. May 2015 B2
9034032 McLean et al. May 2015 B2
9072603 Tuval et al. Jul 2015 B2
9107749 Bobo et al. Aug 2015 B2
9119719 Zipory et al. Sep 2015 B2
9125632 Loulmet et al. Sep 2015 B2
9125742 Yoganathan et al. Sep 2015 B2
9173646 fabro Nov 2015 B2
9180005 Lashinski et al. Nov 2015 B1
9180007 Reich et al. Nov 2015 B2
9192472 Gross et al. Nov 2015 B2
9226825 Starksen et al. Jan 2016 B2
9241702 Maisano et al. Jan 2016 B2
9265608 Miller et al. Feb 2016 B2
9326857 Cartledge et al. May 2016 B2
9351830 Gross et al. May 2016 B2
9414921 Miller et al. Aug 2016 B2
9427316 Schweich et al. Aug 2016 B2
9474606 Zipory et al. Oct 2016 B2
9526613 Gross et al. Dec 2016 B2
9561104 Miller et al. Feb 2017 B2
20010021874 Carpentier Sep 2001 A1
20010044656 Williamson Nov 2001 A1
20020022862 Grafton et al. Feb 2002 A1
20020029080 Mortier Mar 2002 A1
20020042621 Liddicoat Apr 2002 A1
20020082525 Oslund et al. Jun 2002 A1
20020087048 Brock et al. Jul 2002 A1
20020103532 Langberg et al. Aug 2002 A1
20020133180 Ryan et al. Sep 2002 A1
20020151916 Muramatsu Oct 2002 A1
20020151961 Lashinski Oct 2002 A1
20020151970 Garrison Oct 2002 A1
20020169358 Mortier et al. Nov 2002 A1
20020173841 Ortiz et al. Nov 2002 A1
20020177904 Huxel et al. Nov 2002 A1
20020188301 Dallara et al. Dec 2002 A1
20020198586 Inoue Dec 2002 A1
20030018358 Saadat Jan 2003 A1
20030050693 Quijano et al. Mar 2003 A1
20030078465 Pai et al. Apr 2003 A1
20030078653 Vesely Apr 2003 A1
20030083742 Spence May 2003 A1
20030100943 Bolduc May 2003 A1
20030105519 Fasol et al. Jun 2003 A1
20030114901 Loeb et al. Jun 2003 A1
20030120340 Liska et al. Jun 2003 A1
20030130731 Vidlund Jul 2003 A1
20030144657 Bowe et al. Jul 2003 A1
20030167062 Gambale et al. Sep 2003 A1
20030171760 Gambale Sep 2003 A1
20030191528 Quijano et al. Oct 2003 A1
20030199974 Lee et al. Oct 2003 A1
20030204195 Keane Oct 2003 A1
20030229350 Kay Dec 2003 A1
20030229395 Cox Dec 2003 A1
20030233142 Morales et al. Dec 2003 A1
20040010287 Bonutti Jan 2004 A1
20040019359 Worley et al. Jan 2004 A1
20040019377 Taylor Jan 2004 A1
20040024451 Johnson et al. Feb 2004 A1
20040039442 St. Goar et al. Feb 2004 A1
20040049207 Goldfarb et al. Mar 2004 A1
20040059413 Argento Mar 2004 A1
20040092962 Thornton et al. May 2004 A1
20040122448 Levine Jun 2004 A1
20040122514 Forgarty et al. Jun 2004 A1
20040127982 Machold et al. Jul 2004 A1
20040127983 Mortier et al. Jul 2004 A1
20040133220 Lashinski et al. Jul 2004 A1
20040133274 Webler Jul 2004 A1
20040133374 Kattan Jul 2004 A1
20040138744 Lashinski et al. Jul 2004 A1
20040138745 Macoviak et al. Jul 2004 A1
20040148019 Vidlund et al. Jul 2004 A1
20040148020 Vidlund et al. Jul 2004 A1
20040148021 Cartledge et al. Jul 2004 A1
20040153146 Lashinski et al. Aug 2004 A1
20040172046 Hlavka Sep 2004 A1
20040176788 Opolski Sep 2004 A1
20040181287 Gellman Sep 2004 A1
20040186566 Hindrichs Sep 2004 A1
20040193191 Starksen et al. Sep 2004 A1
20040236419 Milo Nov 2004 A1
20040243227 Starsken et al. Dec 2004 A1
20040249453 Cartledge Dec 2004 A1
20040260317 Bloom et al. Dec 2004 A1
20040260393 Randert et al. Dec 2004 A1
20040260394 Douk et al. Dec 2004 A1
20040267358 Reitan Dec 2004 A1
20050004668 Aklog et al. Jan 2005 A1
20050010287 Macoviak et al. Jan 2005 A1
20050010787 Tarbouriech Jan 2005 A1
20050016560 Voughlohn Jan 2005 A1
20050055038 Kelleher et al. Mar 2005 A1
20050055087 Starksen Mar 2005 A1
20050060030 Lashinski et al. Mar 2005 A1
20050065601 Lee et al. Mar 2005 A1
20050070999 Spence Mar 2005 A1
20050075727 Wheatley Apr 2005 A1
20050085903 Lau Apr 2005 A1
20050090827 Gedebou Apr 2005 A1
20050096740 Langberg et al. May 2005 A1
20050107812 Starksen et al. May 2005 A1
20050107871 Realyvasquez et al. May 2005 A1
20050119734 Spence Jun 2005 A1
20050125002 Baran et al. Jun 2005 A1
20050125011 Spence et al. Jun 2005 A1
20050131533 Alfieri Jun 2005 A1
20050137686 Salahieh et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137695 Salahieh Jun 2005 A1
20050159728 Armour et al. Jul 2005 A1
20050171601 Cosgrove et al. Aug 2005 A1
20050177180 Kaganov Aug 2005 A1
20050177228 Solem et al. Aug 2005 A1
20050187613 Bolduc et al. Aug 2005 A1
20050192596 Jugenheimer et al. Sep 2005 A1
20050197696 Gomez Duran Sep 2005 A1
20050203549 Realyvasquez Sep 2005 A1
20050203606 VanCamp Sep 2005 A1
20050216036 Nakao Sep 2005 A1
20050216039 Lederman Sep 2005 A1
20050216079 MaCoviak Sep 2005 A1
20050222665 Aranyi Oct 2005 A1
20050222678 Lashinski et al. Oct 2005 A1
20050256532 Nayak et al. Nov 2005 A1
20050267478 Corradi et al. Dec 2005 A1
20050273138 To et al. Dec 2005 A1
20050288776 Shaoulian et al. Dec 2005 A1
20050288778 Shaoulian Dec 2005 A1
20050288781 Moaddeb et al. Dec 2005 A1
20060004442 Spenser et al. Jan 2006 A1
20060004443 Liddicoat Jan 2006 A1
20060020326 Bolduc et al. Jan 2006 A9
20060020327 Lashinski et al. Jan 2006 A1
20060020333 Lashinski et al. Jan 2006 A1
20060020336 Liddicoat Jan 2006 A1
20060025787 Morales et al. Feb 2006 A1
20060025855 Lashinski et al. Feb 2006 A1
20060025858 Alameddine Feb 2006 A1
20060030885 Hyde Feb 2006 A1
20060041319 Taylor et al. Feb 2006 A1
20060052868 Mortier Mar 2006 A1
20060058871 Zakay et al. Mar 2006 A1
20060069429 Spence et al. Mar 2006 A1
20060074486 Liddicoat Apr 2006 A1
20060085012 Dolan Apr 2006 A1
20060095009 Lampropoulos May 2006 A1
20060106423 Weisel May 2006 A1
20060116757 Lashinski et al. Jun 2006 A1
20060122633 To Jun 2006 A1
20060129166 Lavelle Jun 2006 A1
20060149280 Harvine et al. Jul 2006 A1
20060149368 Spence Jul 2006 A1
20060161265 Levine et al. Jul 2006 A1
20060184240 Jiminez Aug 2006 A1
20060184242 Lichtenstein Aug 2006 A1
20060195134 Crittenden Aug 2006 A1
20060241622 Zergiebel Oct 2006 A1
20060241656 Starksen et al. Oct 2006 A1
20060241748 Lee et al. Oct 2006 A1
20060247763 Slater Nov 2006 A1
20060259135 Navia Nov 2006 A1
20060271175 Woolfson Nov 2006 A1
20060282161 Huyn et al. Dec 2006 A1
20060287661 Bolduc Dec 2006 A1
20060287716 Banbury et al. Dec 2006 A1
20070001627 Lin et al. Jan 2007 A1
20070016287 Cartledge et al. Jan 2007 A1
20070016288 Gurskis Jan 2007 A1
20070021781 Jervis Jan 2007 A1
20070027533 Douk Feb 2007 A1
20070027536 Mihaljevic et al. Feb 2007 A1
20070038221 Fine Feb 2007 A1
20070039425 Wang Feb 2007 A1
20070049942 Hindrichs et al. Mar 2007 A1
20070049970 Belef et al. Mar 2007 A1
20070051377 Douk et al. Mar 2007 A1
20070055206 To et al. Mar 2007 A1
20070061010 Hauser et al. Mar 2007 A1
20070066863 Rafiee et al. Mar 2007 A1
20070078297 Rafiee et al. Apr 2007 A1
20070080188 Spence et al. Apr 2007 A1
20070083168 Whiting et al. Apr 2007 A1
20070100427 Perouse May 2007 A1
20070106328 Wardle et al. May 2007 A1
20070112359 Kimura May 2007 A1
20070112422 Dehdashtian May 2007 A1
20070112425 Schaller et al. May 2007 A1
20070118151 Davidson May 2007 A1
20070118154 Crabtree May 2007 A1
20070118213 Loulmet May 2007 A1
20070118215 Moaddeb May 2007 A1
20070119871 Garcia May 2007 A1
20070142907 Moaddeb Jun 2007 A1
20070162111 Fukamachi et al. Jul 2007 A1
20070198082 Kapadia et al. Aug 2007 A1
20070213582 Zollinger et al. Sep 2007 A1
20070219558 Deutsch Sep 2007 A1
20070233239 Navia et al. Oct 2007 A1
20070239208 Crawford Oct 2007 A1
20070244555 Rafiee et al. Oct 2007 A1
20070244556 Rafiee et al. Oct 2007 A1
20070244557 Rafiee et al. Oct 2007 A1
20070250160 Rafiee Oct 2007 A1
20070255397 Ryan et al. Nov 2007 A1
20070255400 Parravicini et al. Nov 2007 A1
20070270755 Von Oepen et al. Nov 2007 A1
20070270943 Solem et al. Nov 2007 A1
20070276437 Call Nov 2007 A1
20070282375 Hindrichs et al. Dec 2007 A1
20070282429 Hauser et al. Dec 2007 A1
20070295172 Swartz Dec 2007 A1
20070299424 Cumming et al. Dec 2007 A1
20080004697 Lichtenstein et al. Jan 2008 A1
20080027483 Cartledge Jan 2008 A1
20080027555 Hawkins Jan 2008 A1
20080035160 Wodson et al. Feb 2008 A1
20080039935 Buch Feb 2008 A1
20080051703 Thornton et al. Feb 2008 A1
20080058595 Snoke et al. Mar 2008 A1
20080065011 Marchand et al. Mar 2008 A1
20080065204 Mackoviak Mar 2008 A1
20080071366 Tuval Mar 2008 A1
20080086138 Stone et al. Apr 2008 A1
20080086203 Roberts Apr 2008 A1
20080091257 Andreas et al. Apr 2008 A1
20080097523 Bolduc et al. Apr 2008 A1
20080103572 Gerber May 2008 A1
20080125861 Webler et al. May 2008 A1
20080140116 Bonutti Jun 2008 A1
20080167714 St. Goar Jul 2008 A1
20080177382 Hyde et al. Jul 2008 A1
20080195126 Solem Aug 2008 A1
20080195200 Vidlund Aug 2008 A1
20080208265 Frazier et al. Aug 2008 A1
20080221672 Lamphere Sep 2008 A1
20080243245 Thambar Oct 2008 A1
20080262480 Stahler et al. Oct 2008 A1
20080262609 Gross et al. Oct 2008 A1
20080275300 Rothe Nov 2008 A1
20080275469 Fanton Nov 2008 A1
20080275551 Alfieri Nov 2008 A1
20080281411 Berreklouw Nov 2008 A1
20080288044 Osborne Nov 2008 A1
20080288062 Andrieu et al. Nov 2008 A1
20080300537 Bowman Dec 2008 A1
20080300629 Surti Dec 2008 A1
20090028670 Garcia et al. Jan 2009 A1
20090043153 Zollinger et al. Feb 2009 A1
20090043381 Macoviak Feb 2009 A1
20090054969 Salahieh Feb 2009 A1
20090062866 Jackson Mar 2009 A1
20090076586 Hauser Mar 2009 A1
20090076600 Quinn Mar 2009 A1
20090088837 Gillinov Apr 2009 A1
20090093877 Keidar et al. Apr 2009 A1
20090099650 Bolduc Apr 2009 A1
20090105816 Olsen et al. Apr 2009 A1
20090125102 Cartledge May 2009 A1
20090149872 Gross et al. Jun 2009 A1
20090177274 Scorsin Jun 2009 A1
20090171439 Nissl Jul 2009 A1
20090177266 Powell et al. Jul 2009 A1
20090177277 Milo Jul 2009 A1
20090222083 Nguyen et al. Sep 2009 A1
20090248148 Shaolian Oct 2009 A1
20090254103 Deustch Oct 2009 A1
20090259307 Gross et al. Oct 2009 A1
20090264994 Saadat Oct 2009 A1
20090264995 Subramanian Oct 2009 A1
20090287231 Brooks et al. Nov 2009 A1
20090287304 Dahlgren Nov 2009 A1
20090299409 Coe Dec 2009 A1
20090326648 Machold et al. Dec 2009 A1
20100001038 Levin Jan 2010 A1
20100010538 Juravic Jan 2010 A1
20100023117 Yoganathan Jan 2010 A1
20100023118 Medlock et al. Jan 2010 A1
20100030014 Ferrazzi Feb 2010 A1
20100030328 Seguin Feb 2010 A1
20100042147 Janovsky et al. Feb 2010 A1
20100049313 Alon et al. Feb 2010 A1
20100063542 Van der Burg Mar 2010 A1
20100063550 Felix Mar 2010 A1
20100063586 Hasenkam Mar 2010 A1
20100065456 Junk Mar 2010 A1
20100076499 McNamara et al. Mar 2010 A1
20100094248 Nguyen et al. Apr 2010 A1
20100114180 Rock May 2010 A1
20100121349 Meier May 2010 A1
20100121435 Subramanian et al. May 2010 A1
20100121437 Subramanian et al. May 2010 A1
20100130992 Machold et al. May 2010 A1
20100152845 Bloom Jun 2010 A1
20100161041 Maisano et al. Jun 2010 A1
20100161042 Maisano et al. Jun 2010 A1
20100161043 Maisano et al. Jun 2010 A1
20100161047 Cabiri Jun 2010 A1
20100168845 Wright Jul 2010 A1
20100174358 Rabkin et al. Jul 2010 A1
20100179574 Longoria Jul 2010 A1
20100198347 Zakay et al. Aug 2010 A1
20100211166 Miller et al. Aug 2010 A1
20100217184 Koblish et al. Aug 2010 A1
20100217382 Chau Aug 2010 A1
20100234935 Bashiri et al. Sep 2010 A1
20100249915 Zhang Sep 2010 A1
20100249920 Bolling Sep 2010 A1
20100262232 Annest Oct 2010 A1
20100262233 He Oct 2010 A1
20100280603 Maisano et al. Nov 2010 A1
20100280604 Zipory Nov 2010 A1
20100280605 Hammer Nov 2010 A1
20100286628 Gross Nov 2010 A1
20100286767 Zipory Nov 2010 A1
20100305475 Hinchliffe et al. Dec 2010 A1
20100324598 Anderson Dec 2010 A1
20110004210 Johnson Jan 2011 A1
20110004298 Lee et al. Jan 2011 A1
20110009956 Cartledge et al. Jan 2011 A1
20110011917 Loulmet Jan 2011 A1
20110026208 Otsuro et al. Feb 2011 A1
20110029066 Gilad Feb 2011 A1
20110035000 Nieminen et al. Feb 2011 A1
20110066231 Cartledge Mar 2011 A1
20110067770 Pederson et al. Mar 2011 A1
20110071626 Wright et al. Mar 2011 A1
20110082538 Dahlgren et al. Apr 2011 A1
20110087146 Ryan et al. Apr 2011 A1
20110093002 Rucker et al. Apr 2011 A1
20110106245 Miller et al. May 2011 A1
20110106247 Miller May 2011 A1
20110118832 Punjabi May 2011 A1
20110137410 Hacohen Jun 2011 A1
20110144703 Krause Jun 2011 A1
20110166649 Gross Jul 2011 A1
20110184510 Maisano et al. Jul 2011 A1
20110190879 Bobo et al. Aug 2011 A1
20110202130 Cartledge Aug 2011 A1
20110208283 Rust Aug 2011 A1
20110224785 Hacohen Sep 2011 A1
20110230941 Markus Sep 2011 A1
20110230961 Langer Sep 2011 A1
20110238088 Bolduc et al. Sep 2011 A1
20110257433 Walker Oct 2011 A1
20110257633 Cartledge Oct 2011 A1
20110257728 Kuehn Oct 2011 A1
20110264208 Duffy Oct 2011 A1
20110276062 Bolduc Nov 2011 A1
20110282361 Miller et al. Nov 2011 A1
20110288435 Christy et al. Nov 2011 A1
20110288635 Miller Nov 2011 A1
20110301498 Maenhout et al. Dec 2011 A1
20110301698 Miller et al. Dec 2011 A1
20120022557 Cabiri Jan 2012 A1
20120022639 Hacohen et al. Jan 2012 A1
20120022640 Gross et al. Jan 2012 A1
20120022644 Reich Jan 2012 A1
20120035712 Maisano et al. Feb 2012 A1
20120078355 Zipory Mar 2012 A1
20120078359 Li et al. Mar 2012 A1
20120089022 House et al. Apr 2012 A1
20120095552 Spence Apr 2012 A1
20120109155 Robinson et al. May 2012 A1
20120123531 Tsukashima et al. May 2012 A1
20120136436 Cabiri May 2012 A1
20120143323 Hasenkam Jun 2012 A1
20120150290 Gabbay Jun 2012 A1
20120158021 Morrill Jun 2012 A1
20120179086 Shank Jul 2012 A1
20120191182 Hauser et al. Jul 2012 A1
20120197388 Khairkhahan et al. Aug 2012 A1
20120226349 Tuval et al. Sep 2012 A1
20120239142 Liu et al. Sep 2012 A1
20120245604 Tegzes Sep 2012 A1
20120271198 Whittaker et al. Oct 2012 A1
20120283757 Miller Nov 2012 A1
20120296349 Smith et al. Nov 2012 A1
20120296417 Hill et al. Nov 2012 A1
20120296419 Richardson Nov 2012 A1
20120310330 Buchbinder et al. Dec 2012 A1
20120323313 Seguin Dec 2012 A1
20120330410 Hammer Dec 2012 A1
20120330411 Gross Dec 2012 A1
20130023758 Fabro Jan 2013 A1
20130030522 Rowe et al. Jan 2013 A1
20130035759 Gross et al. Feb 2013 A1
20130046373 Cartledge et al. Feb 2013 A1
20130079873 Migliazza Mar 2013 A1
20130297013 Klima et al. Mar 2013 A1
20130085529 Housman Apr 2013 A1
20130090724 Subramanian Apr 2013 A1
20130096672 Reich Apr 2013 A1
20130096673 Hill Apr 2013 A1
20130116776 Gross et al. May 2013 A1
20130116780 Miller May 2013 A1
20130123910 Cartledge May 2013 A1
20130131791 Hlavka et al. May 2013 A1
20130131792 Miller May 2013 A1
20130166017 Cartledge et al. Jun 2013 A1
20130172992 Gross et al. Jul 2013 A1
20130190863 Call et al. Jul 2013 A1
20130190866 Zipory Jul 2013 A1
20130197632 Kovach Aug 2013 A1
20130204361 Adams Aug 2013 A1
20130226289 Shaolian Aug 2013 A1
20130226290 Yellin et al. Aug 2013 A1
20130268069 Zakai et al. Oct 2013 A1
20130289718 Tsukashima et al. Oct 2013 A1
20130304093 Serina et al. Nov 2013 A1
20130325118 Cartledge Dec 2013 A1
20140018914 Zipory et al. Jan 2014 A1
20140088368 Park Mar 2014 A1
20140094826 Sutherland et al. Apr 2014 A1
20140094903 Miller et al. Apr 2014 A1
20140094906 Spence et al. Apr 2014 A1
20140135799 Henderson May 2014 A1
20140142619 Serina et al. May 2014 A1
20140142695 Gross et al. May 2014 A1
20140148849 Serina et al. May 2014 A1
20140148898 Gross et al. May 2014 A1
20140155783 Starksen et al. Jun 2014 A1
20140163670 Alon et al. Jun 2014 A1
20140163690 White Jun 2014 A1
20140188108 Goodine et al. Jul 2014 A1
20140188140 Meier et al. Jul 2014 A1
20140188215 Hlavka et al. Jul 2014 A1
20140194976 Starksen et al. Jul 2014 A1
20140207231 Hacohen et al. Jul 2014 A1
20140222137 Miller et al. Aug 2014 A1
20140243859 Robinson Aug 2014 A1
20140243894 Groothuis et al. Aug 2014 A1
20140243963 Sheps et al. Aug 2014 A1
20140257475 Gross et al. Sep 2014 A1
20140275757 Goodwin et al. Sep 2014 A1
20140276648 Hammer et al. Sep 2014 A1
20140296962 Cartledge et al. Oct 2014 A1
20140303649 Nguyen et al. Oct 2014 A1
20140303720 Sugimoto et al. Oct 2014 A1
20140309661 Sheps et al. Oct 2014 A1
20140309730 Alon Oct 2014 A1
20140324164 Gross et al. Oct 2014 A1
20140343668 Zipory et al. Nov 2014 A1
20140379006 Sutherland et al. Dec 2014 A1
20150012087 Miller et al. Jan 2015 A1
20150018940 Quill et al. Jan 2015 A1
20150051697 Spence et al. Feb 2015 A1
20150081014 Gross et al. Mar 2015 A1
20150105855 Cabiri et al. Apr 2015 A1
20150112432 Reich et al. Apr 2015 A1
20150127097 Neumann et al. May 2015 A1
20150182336 Zipory et al. Jul 2015 A1
20150230924 Miller Aug 2015 A1
20150272586 Herman et al. Oct 2015 A1
20150272734 Sheps et al. Oct 2015 A1
20150282931 Brunnett et al. Oct 2015 A1
20150297212 Reich et al. Oct 2015 A1
20150351906 Hammer et al. Dec 2015 A1
20160008132 Cabin et al. Jan 2016 A1
20160058557 Reich et al. Mar 2016 A1
20160113767 Miller et al. Apr 2016 A1
20160158008 Miller et al. Jun 2016 A1
20160242762 Gilmore et al. Aug 2016 A1
20160262755 Zipory et al. Sep 2016 A1
20160302917 Schewel Oct 2016 A1
20160317302 Madjarov et al. Nov 2016 A1
20160324633 Gross et al. Nov 2016 A1
20160361168 Gross et al. Dec 2016 A1
20160361169 Gross et al. Dec 2016 A1
20170000609 Gross et al. Jan 2017 A1
Foreign Referenced Citations (107)
Number Date Country
2671966 Jun 2008 CA
101653365 Feb 2010 CN
0611561 Aug 1994 EP
0614342 Sep 1994 EP
1006905 Jun 2000 EP
0954257 Aug 2000 EP
1258437 Nov 2002 EP
0871417 Oct 2003 EP
1266641 Oct 2004 EP
1034753 Feb 2005 EP
1258232 Jan 2006 EP
1990014 Nov 2008 EP
1562522 Dec 2008 EP
1420723 Jan 2009 EP
1903991 Sep 2009 EP
1418865 Oct 2009 EP
2119399 Nov 2009 EP
1531762 Apr 2010 EP
1450733 Feb 2011 EP
1861045 Mar 2015 EP
1465555 May 2015 EP
223448 Dec 2012 IL
9205093 Apr 1992 WO
9310714 Jun 1993 WO
1993015690 Aug 1993 WO
9639963 Dec 1996 WO
9640344 Dec 1996 WO
9701369 Jan 1997 WO
9846149 Oct 1998 WO
1999030647 Jun 1999 WO
99033414 Jul 1999 WO
99063907 Dec 1999 WO
99063910 Dec 1999 WO
2000009048 Feb 2000 WO
0022981 Apr 2000 WO
0126586 Apr 2001 WO
0156457 Aug 2001 WO
2001087191 Nov 2001 WO
02085250 Oct 2002 WO
02085251 Oct 2002 WO
02085252 Oct 2002 WO
03028558 Apr 2003 WO
03047467 Jun 2003 WO
2003049647 Jun 2003 WO
2003105667 Dec 2003 WO
2004012583 Feb 2004 WO
2004019816 Mar 2004 WO
2004019826 Mar 2004 WO
04103434 Dec 2004 WO
05021063 Mar 2005 WO
05046488 May 2005 WO
2005062931 Jul 2005 WO
06012013 Feb 2006 WO
06012038 Feb 2006 WO
06086434 Aug 2006 WO
06097931 Sep 2006 WO
06105084 Oct 2006 WO
06116558 Nov 2006 WO
07011799 Jan 2007 WO
2007080595 Jul 2007 WO
07121314 Oct 2007 WO
07136783 Nov 2007 WO
07136981 Nov 2007 WO
2008014144 Jan 2008 WO
2008031103 Mar 2008 WO
08068756 Jun 2008 WO
2009160631 Oct 2009 WO
10004546 Jan 2010 WO
2010000454 Jan 2010 WO
2010006905 Jan 2010 WO
2010044851 Apr 2010 WO
2010065274 Jun 2010 WO
10073246 Jul 2010 WO
2010085649 Jul 2010 WO
2010128502 Nov 2010 WO
2010128503 Nov 2010 WO
2010150178 Dec 2010 WO
2011051942 May 2011 WO
11067770 Jun 2011 WO
2011089401 Jul 2011 WO
2011089601 Jul 2011 WO
2011111047 Sep 2011 WO
2011148374 Dec 2011 WO
2011154942 Dec 2011 WO
2012011108 Jan 2012 WO
2012014201 Feb 2012 WO
2012068541 May 2012 WO
2012106346 Aug 2012 WO
2012176195 Dec 2012 WO
2013021374 Feb 2013 WO
2013021375 Feb 2013 WO
2013069019 May 2013 WO
2013078497 Jun 2013 WO
2013088327 Jun 2013 WO
2014064694 May 2014 WO
2014064695 May 2014 WO
2014064964 May 2014 WO
2014076696 May 2014 WO
2014087402 Jun 2014 WO
2014108903 Jul 2014 WO
2014115149 Jul 2014 WO
2014195786 Dec 2014 WO
2015059699 Apr 2015 WO
2015193728 Dec 2015 WO
2016059639 Apr 2016 WO
2016087934 Jun 2016 WO
2016174669 Nov 2016 WO
Non-Patent Literature Citations (302)
Entry
O'Reilly S et al., “Heart valve surgery pushes the envelope,” Medtech Insight 8(3): 73, 99-108 (2006).
Dieter RS, “Percutaneous valve repair: Update on mitral regurgitation and endovascular approaches to the mitral valve,” Applications in Imaging, Cardiac Interventions, Supported by an educational grant from Amersham Health pp. 11-14 (2003).
Swain CP et al., “An endoscopically deliverable tissue-transfixing device for securing biosensors in the gastrointestinal tract,” Gastrointestinal Endoscopy 40(6): 730-734 (1994).
Odell JA et al., “Early Results o4yf a Simplified Method of Mitral Valve Annuloplasty,” Circulation 92:150-154 (1995).
U.S. Appl. No. 60/873,075, filed Dec. 5, 2006.
An International Preliminary Report on Patentability dated Nov. 9, 2011, which issued during the Prosecution of Applicant's PCT/IL2010/000357.
U.S. Appl. No. 60/902,146, filed Feb. 16, 2007.
An International Preliminary Report on Patentability dated Jun. 5, 2012, which issued during the prosecution of Applicant's PCT/IL2010/001024.
U.S. Appl. No. 61/001,013, filed Oct. 29, 2007.
An International Preliminary Report on Patentability dated Nov. 27, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000404.
U.S. Appl. No. 61/132,295, filed Jun. 16, 2008.
Notice of Allowance dated Apr. 27, 2012, which issued during the prosecution of U.S. Appl. No. 12/341,960.
“Two dimensional real-time ultrasonic imaging of the heart and great vessels”, Mayo Clin Proc. vol. 53:271-303, 1978.
An Office Action dated Mar. 29, 2011, which issued during the prosecution of U.S. Appl. No. 12/341,960.
An Office Action dated Aug. 2, 2011, which issued during the prosecution of U.S. Appl. No. 12/435,291.
A Restriction Requirement dated Mar. 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/785,717.
An International Search Report and a Written Opinion both dated Jun. 10, 2010, which issued during the prosecution of Applicant's PCT/IL09/01209.
An Office Action dated Jan. 27, 2012, which issued during the prosecution of U.S. Appl. No. 12/548,991.
An Office Action dated Apr. 6, 2010, which issued during the prosecution of Applicant's U.S. Appl. No. 12/484,512.
An Office Action dated Nov. 5, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,026.
Notice of Allowance dated Feb. 19, 2014, which issued during the prosecution of U.S. Appl. No. 12/795,192.
An International Search Report and a Written Opinion both dated Aug. 17, 2010, which issued during the prosecution of Applicant's PCT/IL10/00357.
An Office Action dated Sep. 16, 2009 which issued during the prosecution of U.S. Appl. No. 11/950,930.
Alfieri et al., “An effective technique to correct anterior mitral leaflet prolapse,” J Card 14(6):468-470 (1999).
A Restriction Requirement dated Nov. 19, 2012, which issued during the prosecution of U.S. Appl. No. 12/926,673.
Alfieri et al., “The double orifice technique in mitral valve repair: a simple solution for complex problems,” Journal of Thoracic Cardiovascular Surgery 122:674-681 (2001).
A Supplementary European Search Report dated Jan. 20, 2015, which issued during the prosecution European Patent Application No. 12803037.6.
An International Preliminary Report on Patentability dated Jun. 29, 2011, which issued during the prosecution of Applicant's PCT/IL2009/001209.
Alfieri, “The edge-to-edge repair of the mitral valve,” [Abstract] 6th Annual NewEra Cardiac Care: Innovation & Technology, Heart Surgery Forum pp. 103. (2000).
Dang NC et al. “Simplified Placement of Multiple Artificial Mitral Valve Chords,” The Heart Surgery Forum #2005-1005, 8 (3) (2005).
An International Search Report and a Written Opinion both dated Feb. 10, 2011, which issued during the prosecution of Applicant's PCT/IL10/00890.
Alfieri et al.“Novel Suture Device for Beating-Heart Mitral Leaflet Approximation”, Ann Thorac Surg. 2002, 74:1488-1493.
A Notice of Allowance dated Jun. 26, 2012, which issued during the prosecution of U.S. Appl. No. 12/608,316.
An International Search Report and a Written Opinion both dated Sep. 12, 2008, which issued during the prosecution of Applicant's PCT/IL07/01503.
An Office Action dated Jan. 23, 2012, which issued during the prosecution of U.S. Appl. No. 12/692,061.
An International Search Report dated May 19, 2011, which issued during the prosecution of Applicant's PCT/IL2011/00064.
A Supplemenatry European Search Report dated Feb. 1, 2011, which issued during the prosecution of European Patent Application No. EP 07849540.
An International Search Report together with Written Opinion both dated Mar. 30, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001024.
An Office Action dated Aug. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/548,991.
An Office Action dated Jul. 20, 2012, which issued during the prosecution of U.S. Appl. No. 12/843,412.
Notice of Allowance dated Mar. 25, 2015, which issued during the prosecution of U.S. Appl. No. 13/749,153.
An Office Action dated Aug. 24, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,930.
An Office dated May 10, 2012, which issued during the prosectuion of U.S. Appl. No. 12/795,026.
An Office Action dated Mar. 9, 2012, which issued during the prosecution of U.S. Appl. No. 12/689,635.
A Restriction Requirement dated Sep. 14, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,192.
Notice of Allowance dated Dec. 24, 2014, which issued during the prosecution of U.S. Appl. No. 12/795,026.
An Office Action dated Sep. 28, 2011, which issued during the prosecution of U.S. Appl. No. 12/437,103.
An International Search Report and Written Opinion dated Nov. 8, 2010, which issued during the prosecution of Applicant's PCT/IL2010/000358.
An Office Action dated Dec. 29, 2011, which issued during the prosecution of U.S. Appl. No. 12/563,952.
An International Search Report and a Written Opinion both dated Nov. 23, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000446.
An International Search Report with Written Opinion both dated Feb. 2, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000600.
An International Preliminary Report on Patentability dated Nov. 9, 2011 which issued during the prosecution of Applicant's PCT/IL2010/000358.
An Office Action dated Aug. 4, 2010, which issued during the prosecution of U.S. Appl. No. 12/341,960.
An Office Action dated Nov. 14, 2011, which issued during the prosecution of U.S. Appl. No. 12/608,316.
An Office Action dated Aug. 15, 2013, which issued during the prosecution of U.S. Appl. No. 12/795,192.
An Office Action dated Jan. 17, 2013, which issued during the prosecution of U.S. Appl. No. 12/795,192.
An Office Action dated Feb. 12, 2013, which issued during the prosecution of U.S. Appl. No. 12/926,673.
Notice of Allowance dated Dec. 7, 2011, which issued during the prosecution of U.S. Appl. No. 12/435,291.
A Restriction Requirement dated Oct. 27, 2011, which issued during the prosecution of U.S. Appl. No. 12/563,952.
A Notice of Allowance dated May 24, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,952.
A Restriction Requirement dated Jul. 5, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,930.
A Notice of Allowance dated Apr. 3, 2013, which issued during the prosecution of U.S. Appl. No. 12/563,930.
An Office Action dated Apr. 2, 2013, which issued during the prosecution of U.S. Appl. No. 12/785,717.
An Advisory Acion dated Sep. 6, 2012 which issued during the prosecution of U.S. Appl. No. 12/548,991.
A Restriction Requirement dated Feb. 4, 2013 which issued during the prosectuion of U.S. Appl. No. 13/141,606.
An Office Action dated Feb. 14, 2013 which issued during the prosecution of U.S. Appl. No. 13/167,492.
An International Search Report and a Written Opinion both dated Feb. 22, 2013, which issued during the prosecution of Applicant's PCT/IL201/050451.
An Office Action dated Apr. 1, 2013 which issued during the prosecution of U.S. Appl. No. 13/167,476.
A Restriction Requirement dated Jun. 7, 2013 which issued during the prosecution of U.S. Appl. No. 13/141,606.
An Office Action dated Aug. 23, 2013 which issued during the prosecution of U.S. Appl. No. 13/167,444.
U.S. Appl. No. 61/265,936, filed Dec. 2, 2009.
U.S. Appl. No. 61/283,445, filed Dec. 2, 2009.
U.S. Appl. No. 61/207,908, filed Feb. 17, 2009.
Amplatzer Cardiac Plug brochure (English pages), AGA Medical Corporation (Plymouth, MN) (copyright 2008-2010, downloaded Jan. 11, 2011).
An Office Action dated Dec. 16, 2013, which issued during the prosecution of U.S. Appl. No. 13/666,262.
Notice of Allowance dated Nov. 19, 2013, which issued during the U.S. prosecution of U.S. Appl. No. 12/795,192.
An Office Action dated Oct. 2, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,492.
An Office Action dated Nov. 21, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,476.
An Office Action dated Dec. 18, 2013, which issued during the prosecution of U.S. Appl. No. 13/666,141.
A Restriction Requirement dated Apr. 19, 2010 which issued during the prosecution of U.S. Appl. No. 12/341,960.
An Office Action dated Jun. 13, 2012, which issued during the prosecution of U.S. Appl. No. 12/437,103.
An Office Action dated Nov. 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/689,635.
An Office Action dated Oct. 22, 2013, which issued during the prosecution of U.S. Appl. No. 12/926,673.
A Restriction Requirement dated Oct. 25, 2012 which issued during the prosecution of U.S. Appl. No. 13/167,444.
An Office Action dated Jan. 17, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,444.
A Restriction Requirement dated Nov. 2, 2012, which issued during the prosecution of U.S. Appl. No. 13/167,492.
An International Preliminary Report on Patentability dated Feb. 4, 2014, which issued during the prosecution of Applicant's PCT/IL2011/000446.
A Supplementary European Search Report dated Dec. 4, 2012, which issued during the prosecution of European Patent Application No. EP 09834225.6.
A Supplementary European Search Report dated Mar. 28, 2013, which issued during the prosecution of European Patent Application No. EP 1077 2091.4.
U.S. Appl. No. 61/733,979, filed Dec. 6, 2012.
U.S. Appl. No. 61/717,303, filed Oct. 23, 2012.
U.S. Appl. No. 61/820,979, filed May 8, 2013.
U.S. Appl. No. 61/745,848, filed Dec. 6, 2012.
An Office Action dated May 19, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868.
An Office Action dated Sep. 1, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868.
An Office Action dated Dec. 27, 2013, which issued during the prosecution of U.S. Appl. No. 12/785,717.
An Office Action dated May 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/706,868.
An Office Action dated Apr. 7, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,007.
An International Preliminary Report of Patentability dated Jan. 29, 2013, which issued during the prosecution of Applicant's PCT/IL2011/000600.
An International Search Report and a Written Opinion both dated Dec. 6, 2012 which issued during the prosecution of Applicant's PCT/IL2012/000250.
Notice of Allowance dated Nov. 13, 2014, which issued during the prosecution of U.S. Appl. No. 12/795,026.
U.S. Appl. No. 61/557,082, filed Nov. 8, 2011.
A Restriction Requirement dated Jul. 12, 2011, which issued during the prosecution of U.S. Appl. No. 12/437,103.
An Office Action dated Mar. 27, 2013, which issued during the prosecution of U.S. Appl. No. 12/843,412.
An Office Action dated May 6, 2013, which issued during the prosecution of U.S. Appl. No. 12/689,693.
A Restriction Requirement dated May 1, 2012, which issued during the prosecution of U.S. Appl. No. 12/843,412.
Langer et al. Ring plus String: Papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation, The Journal of Thoracic Cardiovascular surgery vol. 133 No. 1, Jan. 2007.
Langer et al. Ring+String, Successful Repair technique for ischemic mitral regurgitation with severe leaflet Tethering, The Department of Thoracic Cardiovascular surgery, Hamburg, Germany, Nov. 2008.
U.S. Appl. No. 61/555,570, filed Nov. 4, 2011.
A Notice of Allowance dated Sep. 18, 2012, which issued during the prosecution of U.S. Appl. No. 12/706,868.
An Office Action dated Aug. 13, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694.
An Office Action dated Dec. 31, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694.
A Restriction Requirement dated Apr. 1, 2011, which issued during the prosecution of U.S. Appl. No. 12/608,316.
Agarwal et al. International Cardiology Perspective Functional Tricuspid Regurgitation, Circ Cardiovasc Interv 2009;2;2;565-573 (2009).
An Office Action dated Oct. 6, 2010, which issued during the prosecution of Applicant's U.S. Appl. No. 12/484,512.
An Office Action dated Jul. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/692,061.
An Interview Summary dated Jul. 27, 2011, which issued during the prosecution of U.S. Appl. No. 12/341,960.
A Notice of Allowance dated May 2, 2013, which issued during the prosecution of U.S. Appl. No. 12/843,412.
An Office Action dated Jul. 18, 2013, which issued during the prosecution of U.S. Appl. No. 13/044,694.
Search Report in European Patent Application 10772090.6 dated Jan. 17, 2014.
An Office Action dated Feb. 3, 2014, which issued during the prosecution of U.S. Appl. No. 12/689,693.
Communication regarding amended claims filed dated Dec. 27, 2012, regarding Euopean App No. 11792047.0.
Notice of Allowance dated Mar. 6, 2014, which issued during the prosecution of U.S. Appl. No. 12/437,103.
An Office Action dated Oct. 9, 2013, which issued during the prosecution of U.S. Appl. No. 12/996,954.
AMPLATZER® Septal Occluder. A patient guide to the Non-Surgical Closuer of the Atrial Septal Defect Using the AMPLATZER Septal Occluder System, AGA Medical Corporation, Apr. 2008.
Notice of Allowance dated Sep. 12, 2014, which issued during the prosecution of U.S. Appl. No. 11/950,930.
An Office Action dated Dec. 19, 2013, which issued during the prosecution of U.S. Appl. No. 14/027,934.
An International Preliminary Report on Patentability dated Dec. 18, 2010, which issued during the prosecution of Applicant's PCT/IL09/00593.
An English translation of an Office Action dated Apr. 23, 2014 which issued during the prosecution of Chinese Patent Application No. 201080059948.4.
Notice of Allowance dated Jun. 23, 2014, which issued during the prosecution of U.S. Appl. No. 12/548,991.
Notice of Allowance dated Jun. 11, 2014, which issued during the prosecution of U.S. Appl. No. 12/689,693.
Notice of Allowance dated Jun. 25, 2014, which issued during the prosecution of U.S. Appl. No. 13/666,262.
An International Search Report and Written Opinion both dated Apr. 9, 2014, which issued during the prosecution of Applicant's PCT/IL13/50860.
Notice of Allowance dated Nov. 7, 2014, which issued during the prosecution of U.S. Appl. No. 13/167,492.
An Office Action dated Jun. 11, 2014, which issued during the prosecution of U.S. Appl. No. 14/027,934.
A Restriction Requirement dated Jun. 2, 2014, which issued during the prosecution of U.S. Appl. No. 13/319,030.
Brennan, Jennifer, 510(k) Summary of safety and effectiveness, Jan. 2008.
A communication from the European Patent Office dated Sep. 28, 2011 which issued during the prosecution of European Application No. 09834225.6.
A Restriction Requirement dated Sep. 17, 2012, which issued during the prosecution of U.S. Appl. No. 12/689,693.
An Office Action dated Aug. 22, 2014, which issued during the prosecution of U.S. Appl. No. 14/027,934.
An Office Action dated Aug. 26, 2014 which issued during the prosecution of U.S. Appl. No. 13/167,444.
Communication dated Jul. 25, 2014, issued by the State Intellectual Property Office of the P.R. of China in counterpart Application No. 200980157331.3.
An Office Action dated Oct. 14, 2014, which issued during the prosecution of U.S. Appl. No. 13/319,030.
Supplementary European Search Report dated Oct. 23, 2014 which issued during the prosecution of Applicant's European App No. 10826224.7.
An International Search Report & Written Opinion both dated Mar. 21, 2014, which issued during the prosecution of Applicant's PCT/IL13/50992.
An Office Action dated Sep. 29, 2014, which issued during the prosecution of U.S. Appl. No. 13/504,870.
An Office Action dated Oct. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/749,153.
An International Search Report & Written Opinion both dated Sep. 8, 2009, which issued during the prosecution of Applicant's PCT/IL09/00593.
An International Preliminary Report on Patentability dated Jun. 10, 2009, which issued during the prosecution of Applicant's PCT/IL07/01503.
Notice of Allowance dated Jan. 22, 2015, which issued during the prosecution of U.S. Appl. No. 13/167,444.
Notice of Allowance dated Dec. 9, 2014, which issued during the prosecution of U.S. Appl. No. 13/167,476.
An English translation of an Office Action dated Dec. 12, 2013 which issued during the prosecution of Chinese Patent Application No. 200980157331.3.
An International Search Report and a Written Opinion both dated Nov. 14, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000404.
Dictionary.com definition of “lock”, Jul. 29, 2013.
A Restriction Requirement dated Jan. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,026.
A Restriction Requirement dated Nov. 14, 2011 which issued during the prosecution of U.S. Appl. No. 12/548,991.
An Office Action dated Jan. 13, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013.
A Notice of Allowance dated May 22, 2013, which issued during the prosecution of U.S. Appl. No. 12/689,635.
An International Preliminary Report on Patentability dated May 1, 2012, which issued during the prosecution of Applicant's PCT/IL2010/000890.
A Notice of Allowance dated Jan. 7, 2014, which issued during the prosecution of U.S. Appl. No. 12/926,673.
Restriction Requirement dated May 5, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868.
Supplementary European Search Report dated Aug. 4, 2014 which issued during the prosecution of Applicant's European App No. 11 81 1934.6.
An Office Action dated Aug. 5, 2010 which issued during the prosecution of U.S. Appl. No. 11/950,930.
An Office Action dated Feb. 17, 2010 which issued during the prosecution of U.S. Appl. No. 11/950,930.
Restriction Requirement dated Nov. 14, 2011, which issued during the prosecution of U.S. Appl. No. 12/689,635.
Supplementary European Search Report dated Jan. 21, 2014 which issued during the prosecution of Applicant's European App No. 11 78 6226.
An Office Action dated Jun. 4, 2014, which issued during the prosecution of U.S. Appl. No. 12/840,463.
Maisano, The double-orifice technique as a standardized approach to treat mitral . . . , European Journal of Cardio-thoracic Surgery 17 (2000) 201-205.
AMPLATZER® Cribriform Occluder. A patient guide to Percutaneous, Transcatheter, Atrial Septal Defect Closuer, AGA Medical Corporation, Apr. 2008.
An Office Action dated Jun. 10, 2014, which issued during the prosecution of U.S. Appl. No. 13/167,492.
Supplementary European Search Report dated Sep. 25, 2015, which issued during the prosecution of Applicant's European App No. 09794095.1.
An Office Action dated Apr. 2, 2015, which issued during the prosecution of U.S. Appl. No. 14/027,934.
An Office Action dated Mar. 23, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013.
Supplementary European Search Report dated Dec. 23, 2014 which issued during the prosecution of Applicant's European App No. 10834311.
An Office Action dated Mar. 24, 2015, which issued during the prosecution of U.S. Appl. No. 12/996,954.
Notice of Allowance dated Dec. 20, 2013, which issued during the prosecution of U.S. Appl. No. 12/437,103.
An International Preliminary Report on Patentability dated Dec. 23, 2014, which issued during the prosecution of Applicant's PCT/IL2012/050451.
An International Preliminary Report on Patentability dated Dec. 23, 2013, which issued during the prosecution of Applicant's PCT/IL2012/000250.
An Office Action dated Oct. 5, 2015, which issued during the prosecution of U.S. Appl. No. 14/246,417.
An Office Action dated Aug. 7, 2015, which issued during the prosecution of U.S. Appl. No. 14/128,756.
An Invitation to pay additional fees dated Jan. 31, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050861.
An Invitation to pay additional fees dated Jan. 31, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050860.
An Office Action dated Sep. 19, 2014, which issued during the prosecution of U.S. Appl. No. 13/044,694.
A communication from the European Patent Office dated Oct. 19, 2012 which issued during the prosecution of European Application No. 11792047.0.
An Office Action dated Oct. 5, 2012, which issued during the prosecution of U.S. Appl. No. 12/996,954.
An Office Action dated Oct. 1, 2015, which issued during the prosecution of U.S. Appl. No. 14/141,228.
Notice of Allowance dated May 6, 2016, which issued during the prosecution of U.S. Appl. No. 14/667,090.
Notice of Allowance dated Apr. 12, 2016, which issued during the prosecution of U.S. Appl. No. 14/667,090.
Ammendment, Terminal Disclaimer and Extension dated Jun. 27, 2012, which issued during the prosecution of U.S. Appl. No. 12/548,991.
An Office Action dated Jun. 18, 2015, which issued during the prosecution of U.S. Appl. No. 14/551,951.
A Notice of Allowance dated Feb. 2, 2015, which issued during the prosecution of U.S. Appl. No. 13/504,870.
An Office Action dated Jan. 5, 2016, which issued during the prosecution of U.S. Appl. No. 14/027,934.
An Office Action dated Mar. 16, 2015, which issued during the prosecution of U.S. Appl. No. 14/084,426.
European Search Report dated Jun. 24, 2016, which issued during the prosecution of European Patent Application No. EP 12847363.
An Office Action dated Mar. 24, 2015, which issued during the prosecution of U.S. Appl. No. 14/486,226.
An Office Action dated Jul. 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/246,417.
Notice of Allowance dated May 22, 2015, which issued during the prosecution of U.S. Appl. No. 13/749,153.
An Office Action dated Jun. 18, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,030.
An Office Action dated Jun. 13, 2014, which issued during the prosecution of U.S. Appl. No. 13/141,606.
An English translation of an Office Action dated Jul. 17, 2015 which issued during the prosecution of Chinese Patent Application No. 201080059948.4.
Notice of Allowance dated Sep. 29, 2014, which issued during the prosecution of U.S. Appl. No. 13/141,606.
An International Search Report and a Written Opinion both dated Oct. 27, 2016, which issued during the prosecution of Applicant's PCT/IL2015/050792.
An International Preliminary Report on Patentability dated Jun. 9, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050992.
An Office Action dated May 3, 2016, which issued during the prosecution of U.S. Appl. No. 13/319,030.
A Notice of Allowance dated Sep. 2, 2016, which issued during the prosecution of U.S. Appl. No. 14/027,934.
An Office Action dated Feb. 3, 2015, which issued during the prosecution of U.S. Appl. No. 14/084,426.
Search Report in European Patent Application 10826224.7 dated Nov. 16, 2015.
An International Preliminary Report on Patentability dated Apr. 28, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050861.
An English Translation of an Office Action dated Nov. 24, 2015, which issued during the prosecution of Israel Patent Application No. 223448. (the relevant part only).
Notice of Allowance dated Nov. 12, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,007.
Notice of Allowance dated Jan. 7, 2016, which issued during the prosecution of U.S. Appl. No. 13/319,007.
Notice of Allowance dated Apr. 20, 2011, which issued during the prosecution of U.S. Appl. No. 12/484,512.
Notice of Allowance dated Mar. 23, 2011, which issued during the prosecution of U.S. Appl. No. 12/484,512.
An Office Action dated May 23, 2016, which issued during the prosecution of U.S. Appl. No. 14/209,171.
European Search Report dated Jul. 8, 2016, which issued during the prosecution Applicant's European App No. 13849843.1.
Notice of Allowance dated Nov. 23, 2016, which issued during the prosecution of U.S. Appl. No. 14/141,228.
Supplementary European Search Report dated Mar. 23, 2015, which issued during the prosecution of Applicant's European App No. 11792047.0.
Supplementary European Search Report dated Apr. 29, 2015, which issued during the prosecution of Applicant's European App No. 14200202.
An International Search Report and a Written Opinion both dated Apr. 15, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050861.
Notice of Allowance dated Nov. 17, 2015, which issued during the prosecution of U.S. Appl. No. 14/486,226.
European Search Report dated Nov. 4, 2015, which issued during the prosecution of European Patent Application No. EP 1077 2091.4.
Notice of Allowance dated Dec. 19, 2016, which issued during the prosecution of U.S. Appl. No. 14/242,151.
European Search Report dated Jul. 15, 2016, which issued during the prosecution of Applicant's European App No. 13849947.0.
An Office Action dated Jun. 17, 2016, which issued during the prosecution of U.S. Appl. No. 14/357,040.
Notice of Allowance dated Dec. 30, 2016, which issued during the prosecution of U.S. Appl. No. 13/319,030.
An Office Action dated Mar. 23, 2015, which issued during the prosecution of European Patent Application No. EP 09834225.6.
Notice of Allowance dated Aug. 3, 2015, which issued during the prosecution of U.S. Appl. No. 13/749,153.
A Notice of Allowance dated Sep. 16, 2016, which issued during the prosecution of U.S. Appl. No. 14/027,934.
A Notice of Allowance dated Jul. 30, 2105, which issued during the prosecution of U.S. Appl. No. 13/319,007.
A Notice of Allowance dated Sep. 3, 2014, which issued during the prosecution of U.S. Appl. No. 12/689,693.
An International Preliminary Report on Patentability dated Apr. 28, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050860.
An Office Action dated Jan. 6, 2016, which issued during the prosecution of U.S. Appl. No. 14/128,756.
An Office Action dated Apr. 8, 2016, which issued during the prosecution of U.S. Appl. No. 14/141,228.
An Office Action dated Apr. 7, 2016, which issued during the prosecution of U.S. Appl. No. 14/242,151.
An Office Action dated Jan. 4, 2016, which issued during the prosecution of U.S. Appl. No. 14/589,100.
Communication from the European Patent Office dated Jun. 11, 2015, which issued during the prosecution of European Patent Application No. 11811934.
Notice of Allowance dated Aug. 19, 2013, which issued during the prosecution of U.S. Appl. No. 11/908,906.
An Office Action dated Jun. 8, 2012, which issued during the prosecution of U.S. Appl. No. 11/908,906.
An Office Action dated Dec. 21, 2013, which issued during the prosecution of U.S. Appl. No. 11/908,906.
A Restriction Requirement dated Aug. 5, 2011, which issued during the prosecution of U.S. Appl. No. 11/908,906.
An Office Action dated Oct. 23, 2012, which issued during the prosecution of Japanese Patent Application No. 2009-539871.
U.S. Appl. No. 60/662,616, filed Mar. 17, 2005.
U.S. Appl. No. 60/700,542, filed Jul. 18, 2005.
An Office Action dated May 4, 2016, which issued during the prosecution of U.S. Appl. No. 14/589,100.
An Office Action dated Jun. 14, 2016, which issued during the prosecution of U.S. Appl. No. 14/273,155.
An International Search Report and a Written Opinion both dated Jan. 25, 2016, which issued during the prosecution of Applicant's PCT/IL2015/051027.
An Office Action dated Jan. 5, 2016, which issued during the prosecution of U.S. Appl. No. 14/084,426.
An International Preliminary Report on Patentability dated Apr. 26, 2016, which issued during the prosecution of Applicant's PCT/IL2014/050914.
An Office Action dated May 11, 2016, which issued during the prosecution of U.S. Appl. No. 14/128,756.
An English Translation of an Office Action dated Sep. 15, 2016, which issued during the prosecution of Israel Patent Application No. 243837. (the relevant part only).
Notice of Allowance dated Sep. 14, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013.
Notice of Allowance dated Jul. 24, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013.
Notice of Allowance dated Jul. 8, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013.
Ahmadi, Ali, et al. “Percutaneously adjustable pulmonary artery band.” The Annals of thoracic surgery 60 (1995): S520-S522.
Assad, Renato S. “Adjustable Pulmonary Artery Banding.” (2014).
Ahmadi, A., G. Spillner, and Th Johannesson. “Hemodynamic changes following experimental production and correction of acute mitral regurgitation with an adjustable ring prosthesis.” The Thoracic and cardiovascular surgeon36.06 (1988): 313-319.
Swenson, Orvar. “Internal device for control of urinary incontinence.” Journal of pediatric surgery 7.5 (1972): 542-545.
Park, Sang C., et al. “A percutaneously adjustable device for banding of the pulmonary trunk.” International journal of cardiology 9.4 (1985): 477-484.
Elliott, Daniel S., Gerald W. Timm, and David M. Barrett. “An implantable mechanical urinary sphincter: a new nonhydraulic design concept.” Urology52.6 (1998): 1151-1154.
An Invitation to pay additional fees dated Aug. 18, 2016, which issued during the prosecution of Applicant's PCT/IL2016/050433.
Daebritz, S., et al. “Experience with an adjustable pulmonary artery banding device in two cases: initial success-midterm failure.” The Thoracic and cardiovascular surgeon 47.01 (1999): 51-52.
Notice of Allowance dated Mar. 1, 2017, which issued during the prosecution of U.S. Appl. No. 14/357,040.
An Office Action dated Sep. 6, 2016, which issued during the prosecution of U.S. Appl. No. 14/141,228.
An International Search Report and a Written Opinion both dated Oct. 17, 2016, which issued during the prosecution of Applicant's PCT/IL2016/050433.
An Office Action dated Oct. 21, 2016, which issued during the prosecution of U.S. Appl. No. 14/567,472.
Notice of Allowance dated Jul. 7, 2015, which issued during the prosecution of U.S. Appl. No. 12/996,954.
Notice of Allowance dated Nov. 18, 2016, which issued during the prosecution of U.S. Appl. No. 13/740,582.
Notice of Allowance dated Oct. 20, 2015, which issued during the prosecution of U.S. Appl. No. 12/996,954.
Amendment and Extension dated Apr. 11, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,952.
Notice of Allowance dated Dec. 8, 2016, which issued during the prosecution of U.S. Appl. No. 14/246,417.
Notice of Allowance dated Dec. 21, 2016, which issued during the prosecution of U.S. Appl. No. 14/246,417.
Notice of Allowance dated Dec. 29, 2016, which issued during the prosecution of U.S. Appl. No. 14/246,417.
Notice of Allowance dated Jan. 3, 2017, which issued during the prosecution of U.S. Appl. No. 14/128,756.
Swenson, O. and Malinin, T.I., 1978. An improved mechanical device for control of urinary incontinence. Investigative urology, 15(5), pp. 389-391.
Swenson, O. An experimental implantable urinary sphincter. Invest Urol, Sep. 1976;14(2):100-3.
An International Preliminary Report on Patentability dated Sep. 18, 2007, which issued during the prosecution of Applicant's PCT/IL2006/000342.
An International Search Report and a Written Opinion both dated May 30, 2007, which issued during the prosecution of Applicant's PCT/IL2006/000342.
An Advisory Action dated Feb. 4, 2014, which issued during the prosecution of U.S. Appl. No. 13/167,476.
An English Translation of an Office Action dated May 31, 2012, which issued during the prosecution of Israel Patent Application No. 209946. (the relevant part only).
A Restriction Requirement dated Jul. 8, 2015, which issued during the prosecution of U.S. Appl. No. 14/141,228.
Notice of Allowance dated Sep. 22, 2016, which issued during the prosecution of U.S. Appl. No. 13/740,582.
A Restriction Requirement dated Sep. 4, 2015, which issued during the prosecution of U.S. Appl. No. 14/589,100.
Notice of Allowance dated Jan. 29, 2016, which issued during the prosecution of U.S. Appl. No. 14/551,951.
An International Search Report and a Written Opinion both dated May 28, 2014, which issued during the prosecution of Applicant's PCT/IL14/050027.
An Office Action dated Aug. 22, 2016, which issued during the prosecution of U.S. Appl. No. 14/084,426.
An Office Action dated Dec. 20, 2016, which issued during the prosecution of UK Patent Application No. 1611910.9.
Notice of Allowance dated Aug. 7, 2015, which issued during the prosecution of Chinese Patent Application No. 200980157331.3.
An Office Action dated Jan. 20, 2017, which issued during the prosecution of U.S. Appl. No. 14/650,114.
An Office Action dated Feb. 27, 2017, which issued during the prosecution of U.S. Appl. No. 15/249,957.
An Office Action dated Feb. 2, 2017, which issued during the prosecution of U.S. Appl. No. 14/209,171.
An Office Action dated Jan. 25, 2017, which issued during the prosecution of Chinese Patent Application No. 201510681407.X.
An Office Action dated Dec. 13, 2016, which issued during the prosecution of Applicant's European App No. 11786226.8.
An Interview Summary dated Apr. 4 ,2012, which issued during the prosecution of U.S. Appl. No. 12/563,952.
An Office Action dated Mar. 3, 2017, which issued during the prosecution of Applicant's European App No. 11792047.0.
An Office Action dated May 28, 2015, which issued during the prosecution of U.S. Appl. No. 14/128,756.
An International Search Report & Written Opinion both dated May 12, 2015, which issued during the prosecution of Applicant's PCT/IL2014/050914.
Alfieri et al., “The edge to edge technique,” The European Association for Cardio-Thoracic Surgery 14th Annual Meeting Oct. 7-11, Book of Procees. (2000).
An Office Action dated Feb. 10, 2017, which issued during the prosecution of U.S. Appl. No. 14/990,172.
An Office Action dated Mar. 24, 2017, which issued during the prosecution of U.S. Appl. No. 14/273,155.
U.S. Appl. No. 61/894,486, filed Oct. 23, 2013.
An Office Action dated Apr. 6, 2017, which issued during the prosecution of U.S. Appl. No. 14/437,062.
Notice of Allowance dated Apr. 13, 2017, which issued during the prosecution of U.S. Appl. No. 14/650,114.
Related Publications (1)
Number Date Country
20160262755 A1 Sep 2016 US
Provisional Applications (1)
Number Date Country
61894486 Oct 2013 US